1
|
Carrico M, Frosch C, Craig K, Carter M, Falk J, Guerrero S, Huang L, Kossoudji A, Michelson TR, Miller P, Park C, Solt T, Wakefield BJ. Implementation of Video Blood Pressure Visits in the Veterans Health Administration. Telemed J E Health 2024; 30:1006-1012. [PMID: 37935031 DOI: 10.1089/tmj.2023.0269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2023] Open
Abstract
Introduction: Almost half of veterans (44.6%) seen in the U.S. Department of Veterans Affairs outpatient setting are diagnosed with hypertension (HTN). Because of the widespread nature of HTN, use of virtual visits has the potential to improve blood pressure (BP) management. This evaluation assessed the effectiveness of video blood pressure visits (VBPVs) in the management of HTN in veterans enrolled in Veterans Health Administration primary care. Methods: The program was implemented within the existing veteran-centered medical home. VBPVs are scheduled where the nurse observes veterans taking their BP and provides teaching or counseling. A national training curriculum was delivered to local nurse champions through Microsoft Teams. We analyzed improvement in BP over a 2-year period. We also captured actions taken by nurses during the VBPV by searching the electronic notes. Ratings of training and comments were summarized using feedback forms completed after training. Results: In total, 81,476 veterans participated in VBPVs over 2 years. Of those, 44,682 veterans had an existing ICD-10 code related to HTN. Of the 18,078 veterans who had a pre- and post-VBPV BP, the average change to systolic measurement was -10.6 mm Hg (range -82 to 78). Average change to diastolic measurement was -4.61 mm Hg (range -59 to 55). Most interventions addressed medication management (77%). Nurses' evaluations of the program were positive. Conclusions: Video visits provide reliable and convenient veteran-centered care. Such visits enable care when unanticipated interruptions occur such as the coronavirus disease 2019 pandemic. In addition to medication management, nurse-led interventions such as counseling on lifestyle changes can be effective in HTN management.
Collapse
Affiliation(s)
- Margaret Carrico
- Family Medicine, Tampa Veterans Administration Medical Center, Tampa, Florida, USA
| | - Cortney Frosch
- Implementation Strategies Support Team Lead, Iron Bow Technologies/Veterans Health Administration, Connected Health, Washington, District of Columbia, USA
| | - Kathleen Craig
- Nurse Lead, Video Blood Pressure Program, Boston Veterans Health Administration Medical Center, Boston, Massachusetts, USA
| | - Maia Carter
- Director of Virtual Care Integration, Office of Primary Care, Veterans Health Administration, Washington, District of Columbia, USA
| | - Jami Falk
- Chief Nurse Office of Primary Care Monitoring & Oversight, Office of Primary Care and Oversight, Veterans Health Administration, Washington, District of Columbia, USA
| | - Sandra Guerrero
- Nursing Service, Las Vegas Veterans Health Administration, Las Vegas, Nevada, USA
| | - Lisa Huang
- Librarian, VA Eastern Colorado Health Care System, Aurora, Colorado, USA
| | - Andrea Kossoudji
- Nurse Educator, New Jersey War Related Illness and Injury Study Center, East Orange, New Jersey, USA
| | - Trevor R Michelson
- Computer Scientist, Veterans Health Administration, Washington, District of Columbia, USA
| | - Pamela Miller
- Management Analyst, Automated Data Processing Application Coordinator, North Texas Veterans Health Administration Health Care System, Dallas, Texas, USA
| | - Catherine Park
- Research Coordinator, Houston Veterans Health Administration Medical Center, Houston, Texas, USA
| | - Traci Solt
- Director for Clinical Services, Office of Primary Care, Veterans Health Administration, Washington, District of Columbia, USA
| | - Bonnie J Wakefield
- Sinclair School of Nursing, University of Missouri-Columbia, Columbia, Missouri, USA
| |
Collapse
|
2
|
Murphy EP, Murphy RP, McKenna D, Miller P, Doyle R, Hurson C. Improved adherence to hip fracture standards reduces mortality after hip fractures. Surgeon 2024; 22:25-30. [PMID: 37517981 DOI: 10.1016/j.surge.2023.06.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2022] [Revised: 02/11/2023] [Accepted: 06/25/2023] [Indexed: 08/01/2023]
Abstract
BACKGROUND Hip fractures are increasing in incidence due to increasing life expectancy. Mortality continues to improve but it is important to explore which factors are responsible for driving improvements. METHODS A cohort of hip fracture patients predating SARS-CoV-2 was examined to determine the predictors of adherence to the six Irish Hip Fracture Standards (IHFS) and the impact of adherence on short (30 day) and long term (1 year) mortality. Our primary aim was assess the impact of a single HFS and cumulative number of HFS on mortality after hip fracture. Our secondary aim was to determine the impact of the HFS which are intrinsically linked to specialist Geriatric care. RESULTS Across 962 patients, over 5 years, the factors which were associated with adherence to HFS were female gender, increasing ASA grade and being nursed on an orthopaedic ward. Patients with increasing ASA were more likely to have met HFS 4-6 (Geriatrician review HFS4, bone health HFS5 & specialist falls assessment HFS6), less likely to have surgery within 48 h are more likely to develop a pressure ulcer. If the patient was not nursed on an orthopaedic ward all HFS were less likely to be met. At 30 days HFS 4-6 were associated with a statistically significant odds ratio (OR) of being alive, while at one year HFS 1 (admitted to an orthopaedic ward within 4 h), 5 and 6 were associated with a statistically significant OR of being alive. As increasing numbers of hip fracture standards were met patients were more likely to be alive at 30 days and one year. CONCLUSION This study has identified that improved adherence to hip fracture standards are associated with improved mortality at 30 days and one year.
Collapse
Affiliation(s)
- E P Murphy
- Department of Trauma and Orthopaedics, St Vincents University Hospital Elm Park, Dublin 4, Ireland.
| | - R P Murphy
- Department of Geriatric and Stroke Medicine, Saolta Hospital Group, Galway University Hospital, Newcastle Road, Galway, Ireland.
| | - D McKenna
- Department of Trauma and Orthopaedics, St Vincents University Hospital Elm Park, Dublin 4, Ireland.
| | - P Miller
- Department of Trauma and Orthopaedics, St Vincents University Hospital Elm Park, Dublin 4, Ireland.
| | - R Doyle
- Department of Geriatric Medicine, St. Vincents University Hospital Elm Park, Dublin 4, Ireland.
| | - C Hurson
- Department of Trauma and Orthopaedics, St Vincents University Hospital Elm Park, Dublin 4, Ireland.
| |
Collapse
|
3
|
Jordan-Ward R, von Hippel FA, Wilson CA, Rodriguez Maldonado Z, Dillon D, Contreras E, Gardell A, Minicozzi MR, Titus T, Ungwiluk B, Miller P, Carpenter D, Postlethwait JH, Byrne S, Buck CL. Differential gene expression and developmental pathologies associated with persistent organic pollutants in sentinel fish in Troutman Lake, Sivuqaq, Alaska. Environ Pollut 2024; 340:122765. [PMID: 37913975 DOI: 10.1016/j.envpol.2023.122765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/26/2023] [Revised: 10/07/2023] [Accepted: 10/15/2023] [Indexed: 11/03/2023]
Abstract
Persistent organic pollutants (POPs) are lipophilic compounds that bioaccumulate in animals and biomagnify within food webs. Many POPs are endocrine disrupting compounds that impact vertebrate development. POPs accumulate in the Arctic via global distillation and thereby impact high trophic level vertebrates as well as people who live a subsistence lifestyle. The Arctic also contains thousands of point sources of pollution, such as formerly used defense (FUD) sites. Sivuqaq (St. Lawrence Island), Alaska was used by the U.S. military during the Cold War and FUD sites on the island remain point sources of POP contamination. We examined the effects of POP exposure on ninespine stickleback (Pungitius pungitius) collected from Troutman Lake in the village of Gambell as a model for human exposure and disease. During the Cold War, Troutman Lake was used as a dump site by the U.S. military. We found that PCB concentrations in stickleback exceeded the U.S. Environmental Protection Agency's guideline for unlimited consumption despite these fish being low trophic level organisms. We examined effects at three levels of biological organization: gene expression, endocrinology, and histomorphology. We found that ninespine stickleback from Troutman Lake exhibited suppressed gonadal development compared to threespine stickleback (Gasterosteus aculeatus) studied elsewhere. Troutman Lake stickleback also displayed two distinct hepatic phenotypes, one with lipid accumulation and one with glycogen-type vacuolation. We compared the transcriptomic profiles of these liver phenotypes using RNA sequencing and found significant upregulation of genes involved in ribosomal and metabolic pathways in the lipid accumulation group. Additionally, stickleback displaying liver lipid accumulation had significantly fewer thyroid follicles than the vacuolated phenotype. Our study and previous work highlight health concerns for people and wildlife due to pollution hotspots in the Arctic, and the need for health-protective remediation.
Collapse
Affiliation(s)
- Renee Jordan-Ward
- Department of Biological Sciences, Northern Arizona University, 617 S. Beaver St., Flagstaff, AZ 86011, USA
| | - Frank A von Hippel
- Department of Community, Environment and Policy, Mel & Enid Zuckerman College of Public Health, University of Arizona, 1295 N. Martin Ave., P.O. Box 245210, Tucson, AZ 85724, USA.
| | - Catherine A Wilson
- Institute of Neuroscience, University of Oregon, 1254 University of Oregon, Eugene, OR 97403, USA
| | - Zyled Rodriguez Maldonado
- Department of Biological Sciences, Northern Arizona University, 617 S. Beaver St., Flagstaff, AZ 86011, USA
| | - Danielle Dillon
- Department of Biological Sciences, Northern Arizona University, 617 S. Beaver St., Flagstaff, AZ 86011, USA
| | - Elise Contreras
- Department of Biological Sciences, Northern Arizona University, 617 S. Beaver St., Flagstaff, AZ 86011, USA
| | - Alison Gardell
- School of Interdisciplinary Arts and Sciences, University of Washington Tacoma, 1900 Commerce Street, Tacoma, WA 98402, USA
| | - Michael R Minicozzi
- Department of Biological Sciences, Minnesota State University Mankato, 242 Trafton Science Center South, Mankato, MN, 56001, USA
| | - Tom Titus
- Institute of Neuroscience, University of Oregon, 1254 University of Oregon, Eugene, OR 97403, USA
| | - Bobby Ungwiluk
- Alaska Community Action on Toxics, 1225 E. International Airport Road, Suite 220, Anchorage, AK 99518, USA
| | - Pamela Miller
- Alaska Community Action on Toxics, 1225 E. International Airport Road, Suite 220, Anchorage, AK 99518, USA
| | - David Carpenter
- Institute for Health and the Environment, University at Albany, 5 University Place, Rensselaer, NY 12144, USA
| | - John H Postlethwait
- Institute of Neuroscience, University of Oregon, 1254 University of Oregon, Eugene, OR 97403, USA
| | - Samuel Byrne
- Middlebury College, Department of Biology and Global Health Program, 14 Old Chapel Rd, Middlebury, VT 05753, USA
| | - C Loren Buck
- Department of Biological Sciences, Northern Arizona University, 617 S. Beaver St., Flagstaff, AZ 86011, USA
| |
Collapse
|
4
|
Moran IL, Tidwell L, Barton M, Kile M, Miller P, Rohlman D, Seguinot-Medina S, Ungwiluk B, Waghiyi V, Anderson K. Diffusive fluxes of persistent organic pollutants between Arctic atmosphere, surface waters and sediments. Sci Total Environ 2023; 892:164566. [PMID: 37270011 PMCID: PMC10330832 DOI: 10.1016/j.scitotenv.2023.164566] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/24/2023] [Revised: 05/06/2023] [Accepted: 05/28/2023] [Indexed: 06/05/2023]
Abstract
Arctic communities are disproportionately exposed to pollutants from sources including global atmospheric transport and formerly used defense sites (FUDS). The effects of climate change and increasing development in the Arctic have the potential to exacerbate this problem. Yupik People of Sivuqaq, or St Lawrence Island, Alaska are one such community with documented exposures to pollutants from FUDS, and their traditional lipid-rich foods such as blubber and rendered oils of marine mammals. Troutman Lake, adjacent to the Yupik community of Gambell, Alaska, was used as a disposal site during the decommission of the adjacent FUDS, leading to community concern about exposure to military pollution and intrusion from historic local dump sites. In collaboration with a local community group, this study utilized passive sampling devices deployed in Troutman Lake. Air, water and sediment deployed samplers were analyzed for unsubstituted and alkylated polycyclic aromatic hydrocarbons (PAHs), brominated and organophosphate flame retardants and polychlorinated biphenyls (PCBs). PAH concentrations were low and comparable to other remote/rural locations. PAHs were generally in deposition from the overlying atmosphere into Troutman Lake. Of the flame retardants, brominated diphenyl ether-47 was detected in all surface water samplers while triphenyl phosphate was detected in all environmental compartments. Both were at concentrations equivalent or lower than other remote locations. Of particular interest, we measured higher atmospheric concentrations of tris(2-chloroethyl) phosphate (TCEP) (0.75-2.8 ng/m3) than previously reported in the literature for remote Arctic sites (<0.017-0.56 ng/m3). TCEP was found to be in deposition to Troutman Lake at magnitudes from 290 to 1300 ng/m2/day. No PCBs were detected in this study. Our findings demonstrate the relevance of both modern and legacy chemicals from local and global sources. These results help us to understand the fate of anthropogenic contaminants in dynamic Arctic systems providing valuable data for communities, policy makers and scientists.
Collapse
Affiliation(s)
- Ian L Moran
- Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, USA
| | - Lane Tidwell
- Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, USA
| | - Michael Barton
- Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, USA
| | - Molly Kile
- College of Public Health and Human Sciences, Oregon State University, Corvallis, OR, USA
| | - Pamela Miller
- Alaska Community Action on Toxics, Anchorage, AK, USA
| | - Diana Rohlman
- Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, USA; College of Public Health and Human Sciences, Oregon State University, Corvallis, OR, USA
| | | | | | - Vi Waghiyi
- Alaska Community Action on Toxics, Anchorage, AK, USA
| | - Kim Anderson
- Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, USA.
| |
Collapse
|
5
|
Lancelot M, Fibben K, Sullivan J, O’Sick W, McLendon K, Wu H, Rao A, Bassit LC, Greenleaf M, Miller P, Krull W, Tyburski E, Roback JD, Lam WA, Damhorst GL. Effect of swab pooling on the Accula point-of-care RT-PCR for SARS-CoV-2 detection. Front Microbiol 2023; 14:1219214. [PMID: 37608952 PMCID: PMC10440424 DOI: 10.3389/fmicb.2023.1219214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2023] [Accepted: 07/26/2023] [Indexed: 08/24/2023] Open
Abstract
Introduction Swab pooling may allow for more efficient use of point-of-care assays for SARS-CoV-2 detection in settings where widespread testing is warranted, but the effects of pooling on assay performance are not well described. Methods We tested the Thermo-Fisher Accula rapid point-of-care RT-PCR platform with contrived pooled nasal swab specimens. Results We observed a higher limit of detection of 3,750 copies/swab in pooled specimens compared to 2,250 copies/swab in individual specimens. Assay performance appeared worse in a specimen with visible nasal mucous and debris, although performance was improved when using a standard laboratory mechanical pipette compared to the transfer pipette included in the assay kit. Conclusion Clinicians and public health officials overseeing mass testing efforts must understand limitations and benefits of swab or sample pooling, including reduced assay performance from pooled specimens. We conclude that the Accula RT-PCR platform remains an attractive candidate assay for pooling strategies owing to the superior analytical sensitivity compared to most home use and point-of-care tests despite the inhibitory effects of pooled specimens we characterized.
Collapse
Affiliation(s)
- Moira Lancelot
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States
| | - Kirby Fibben
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, United States
| | - Julie Sullivan
- The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Atlanta, GA, United States
- Department of Pediatrics, Emory University School of Medicine and Children’s Healthcare of Atlanta, Atlanta, GA, United States
| | - William O’Sick
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States
| | - Kaleb McLendon
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States
| | - Huixia Wu
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States
| | - Anuradha Rao
- The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Atlanta, GA, United States
- Department of Pediatrics, Emory University School of Medicine and Children’s Healthcare of Atlanta, Atlanta, GA, United States
| | - Leda C. Bassit
- The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Atlanta, GA, United States
- Department of Pediatrics, Emory University School of Medicine and Children’s Healthcare of Atlanta, Atlanta, GA, United States
- Laboratory of Biochemical Pharmacology, Emory University, Atlanta, GA, United States
| | - Morgan Greenleaf
- The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Atlanta, GA, United States
| | - Pamela Miller
- Rapid Acceleration of Diagnostics (RADx), Maryland, MD, United States
| | - Wolfgang Krull
- Rapid Acceleration of Diagnostics (RADx), Maryland, MD, United States
| | - Erika Tyburski
- The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Atlanta, GA, United States
| | - John D. Roback
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States
| | - Wilbur A. Lam
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, United States
- The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Atlanta, GA, United States
- Department of Pediatrics, Emory University School of Medicine and Children’s Healthcare of Atlanta, Atlanta, GA, United States
- Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, GA, United States
| | - Gregory L. Damhorst
- The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Atlanta, GA, United States
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States
| |
Collapse
|
6
|
Miller P. Protecting the health of future generations in the arctic through community-based participatory research and action. Explore (NY) 2023; 19:271-272. [PMID: 36653271 PMCID: PMC10775922 DOI: 10.1016/j.explore.2022.12.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Affiliation(s)
- Pamela Miller
- Alaska Community Action on Toxics (ACAT), United States.
| |
Collapse
|
7
|
Wilson-Robles H, Warry E, Miller T, Jarvis J, Matsushita M, Miller P, Herzog M, Turatsinze JV, Kelly TK, Butera ST, Michel G. Monitoring plasma nucleosome concentrations to measure disease response and progression in dogs with hematopoietic malignancies. PLoS One 2023; 18:e0281796. [PMID: 37163491 PMCID: PMC10171669 DOI: 10.1371/journal.pone.0281796] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Accepted: 04/12/2023] [Indexed: 05/12/2023] Open
Abstract
BACKGROUND Hematopoietic malignancies are extremely common in pet dogs and represent nearly 30% of the malignancies diagnosed in this population each year. Clinicians commonly use existing tools such as physical exam findings, radiographs, ultrasound and baseline blood work to monitor these patients for treatment response and remission. Circulating biomarkers, such as prostate specific antigen or carcinoembryonic antigen, can be useful tools for monitoring treatment response and remission status in human cancer patients. To date, there has a been a lack of useful circulating biomarkers available to veterinary oncology patients. METHODS Circulating plasma nucleosome concentrations were evaluated at diagnosis, throughout treatment and during remission monitoring for 40 dogs with lymphoma, acute myelogenous leukemia and multiple myeloma. Additionally, C-reactive protein and thymidine kinase-1 levels were recorded. RESULTS Plasma nucleosome concentrations were significantly higher at diagnosis and progressive disease than they were when dogs were in remission. All but two dogs had plasma nucleosome concentrations that returned to the low range during treatment. These two dogs had the shortest progression free and overall survival times. Dogs with the highest plasma nucleosome concentrations had a significantly shorter first progression free survival than dogs with lower plasma nucleosome concentrations at diagnosis. Plasma nucleosome concentrations correlated better with disease response and progression than either thymidine kinase or C reactive protein. CONCLUSIONS Plasma nucleosome concentrations can be a useful tool for treatment monitoring and disease progression in dogs with hematopoietic malignancies.
Collapse
Affiliation(s)
- Heather Wilson-Robles
- Small Animal Clinical Sciences Department, Texas A&M University, College Station, Texas, United States of America
- Volition Veterinary Diagnostics Development, Henderson, Nevada, United States of America
| | - Emma Warry
- Small Animal Clinical Sciences Department, Texas A&M University, College Station, Texas, United States of America
| | - Tasha Miller
- Small Animal Clinical Sciences Department, Texas A&M University, College Station, Texas, United States of America
| | - Jill Jarvis
- Small Animal Clinical Sciences Department, Texas A&M University, College Station, Texas, United States of America
| | - Matthew Matsushita
- Small Animal Clinical Sciences Department, Texas A&M University, College Station, Texas, United States of America
| | - Pamela Miller
- Small Animal Clinical Sciences Department, Texas A&M University, College Station, Texas, United States of America
| | - Marielle Herzog
- Belgian Volition SRL, Parc Scientifique Crealys, Isnes, Belgium
| | | | - Theresa K Kelly
- Volition America LLC, Henderson, Nevada, United States of America
| | - S Thomas Butera
- Volition Veterinary Diagnostics Development, Henderson, Nevada, United States of America
| | - Gaetan Michel
- Belgian Volition SRL, Parc Scientifique Crealys, Isnes, Belgium
- Volition America LLC, Henderson, Nevada, United States of America
| |
Collapse
|
8
|
Chauhan AJ, Eriksson G, Storrar W, Brown T, Peterson S, Radner F, D’Cruz LG, Miller P, Bjermer L. Temperature-controlled Laminar Airflow (TLA) in symptomatic severe asthma – a post hoc analysis of severe exacerbations, quality of life and health economics. BMC Pulm Med 2022; 22:407. [DOI: 10.1186/s12890-022-02205-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2022] [Accepted: 10/25/2022] [Indexed: 11/11/2022] Open
Abstract
Abstract
Purpose
Uncontrolled severe asthma constitutes a major economic burden to society. Add-ons to standard inhaled treatments include inexpensive oral corticosteroids and expensive biologics. Nocturnal treatment with Temperature-controlled Laminar Airflow (TLA; Airsonett®) could be an effective, safe and cheaper alternative. The potential of TLA in reducing severe asthma exacerbations was addressed in a recent randomised placebo-controlled trial (RCT) in patients with severe asthma (Global Initiative for Asthma (GINA) step 4/5), but the results were inconclusive. We re-analysed the RCT with severe exacerbations stratified by the level of baseline asthma symptoms and Quality of Life.
Methods
More uncontrolled patients, defined by Asthma Control Questionnaire 7 (ACQ7) > 3, EuroQoL 5-Dimension Questionnaire Visual Analogue Scale (EQ5D-VAS) ≤ 65 and Asthma Quality of Life Questionnaire (AQLQ) ≤ 4 were selected for re-analysis. The rates of severe asthma exacerbations, changes in QoL and health-economics were analysed and compared between TLA and placebo.
Results
The study population included 226 patients (113 TLA / 113 placebo.) The rates of severe asthma exacerbations were reduced by 33, 31 and 25% (p = 0.083, 0.073, 0.180) for TLA compared to placebo, dependent on selected control measures (ACQ7, EQ5D-VAS, AQLQ, respectively). For patients with less control defined by AQLQ≤4, the difference in mean AQLQ0-12M between TLA and placebo was 0.31, 0.33, 0.26 (p = 0.085, 0.034, 0.150), dependent on selected covariate (AQLQ, EQ5D-VAS, ACQ7, respectively). For patients with poor control defined by ACQ7 > 3, the difference in EQ5D-5 L utility scores between TLA and placebo was significant at 9 and 12 months with a cost-effective ICER. The results from the original study did not demonstrate these differences.
Conclusion
This post hoc analysis demonstrated an effect of TLA over placebo on severe exacerbations, asthma control and health economics in a subgroup of patients with more symptomatic severe allergic asthma. The results are consistent with the present recommendations for TLA. However, these differences were not demonstrated in the full study. Several explanations for the different outcomes have been outlined, which should be addressed in future studies.
Funding
NIHR Health Technology Assessment Programme and Portsmouth Hospitals NHS Trust.
Collapse
|
9
|
Byrne S, Seguinot-Medina S, Waghiyi V, Apatiki E, Immingan T, Miller P, von Hippel FA, Buck CL, Carpenter DO. PFAS and PBDEs in traditional subsistence foods from Sivuqaq, Alaska. Environ Sci Pollut Res Int 2022; 29:77145-77156. [PMID: 35672645 PMCID: PMC9588546 DOI: 10.1007/s11356-022-20757-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/31/2021] [Accepted: 05/07/2022] [Indexed: 06/15/2023]
Abstract
The Arctic is a hemispheric sink for both legacy and current use persistent organic pollutants (POPs). Once in the Arctic, POPs biomagnify in food webs, potentially reaching concentrations in high trophic level animals that pose a health concern for people who subsist on those animals. Indigenous Peoples of the Arctic may be highly exposed to POPs through their traditional diets. The objective of this study was to assess concentrations of polybrominated diphenyl ethers (PBDEs) and per- and polyfluoroalkyl substances (PFAS) in tissues of traditionally harvested foods from Sivuqaq (St. Lawrence Island), Alaska. Community health researchers identified volunteer households and local hunters to donate tissues from traditionally harvested animals. Target species included bowhead whale (Balaena mysticetus), Pacific walrus (Odobenus rosmarus), ringed seal (Pusa hispida), bearded seal (Erignathus barbatus), ribbon seal (Histriophoca fasciata), spotted seal (Phoca largha), and reindeer (Rangifer tarandus). PBDEs were frequently detected in all species and tissues. PBDE concentrations tended to be highest in lipid-rich tissues of seals. PFAS were infrequently detected and did not show obvious patterns among species or tissues. This and other studies demonstrate that POPs such as PBDEs are present in tissues of traditional food animals from Sivuqaq, as they are throughout the Arctic, and consumption of these animals likely contributes to exposure among Arctic Indigenous Peoples.
Collapse
Affiliation(s)
- Sam Byrne
- Department of Biology, Global Health Program, Middlebury College, Bicentennial Hall, Bicentennial Way, VT, 05753, Middlebury, USA.
| | | | - Vi Waghiyi
- Alaska Community Action on Toxics, Anchorage, AK, USA
| | | | | | - Pamela Miller
- Alaska Community Action on Toxics, Anchorage, AK, USA
| | - Frank A von Hippel
- Department of Community, Environment & Policy, University of Arizona, Tucson, AZ, USA
| | - Charles Loren Buck
- Department of Biological Sciences, Northern Arizona University, Flagstaff, AZ, USA
| | - David O Carpenter
- Institute for Health and the Environment, University at Albany, Albany, NY, USA
| |
Collapse
|
10
|
O'Donovan C, Samida S, Reynolds S, Miller P, Burrows S. 147 ESTABLISHING A PERI-OPERATIVE MEDICAL SERVICE (POMS) FOR OLDER PEOPLE IN UROLOGY. Age Ageing 2022. [DOI: 10.1093/ageing/afac218.124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Older adults account for approximately 65% of patients undergoing urological procedures therefore as the population ages the demand is anticipated to rise. The benefits of Comprehensive Geriatric Assessment (CGA) have been proven in ortho-geriatrics and a number of surgical specialties but evidence in urology is lacking. The aim of this study was to assess the impact of a Peri-Operative Medical Service for older people (POMS) on patient outcomes in a urology inpatient population.
Methods
This was a single-centre retrospective study of patients ≥50 years with length of stay (LOS) >1 day admitted over two four month periods in 2018 (Pre-intervention) and 2019 (Intervention). Group differences in LOS and complications were examined using univariate regressions and then adjusted for sex, emergency admission, severity of procedure and Charlson Co-morbidity Index which also accounts for age. Secondary outcomes were to record undiagnosed medical conditions identified and the interventions made by the POMS.
Results
There were a total of 218 admissions from 211 patients with equal numbers of admissions in both the pre-intervention and intervention groups. No significant differences were detected for LOS (median 3 vs 4 days, p=0.11) or complications (32(29%) vs 40(37%), p=0.23) between pre-intervention and intervention groups. A new medical diagnosis was made in 13 (12%) of the pre-intervention v 43(39%) of the intervention group (p<0.001). The POMS recommended a change to management in 102 admissions (94%). The most common intervention was medication review: 64(59%) v 19(17%) (p<0.001).
Conclusion
The Peri-Operative Medical Service for older people can improve patient management by identifying and managing medical issues, complications and geriatric syndromes that may otherwise have been missed.
Collapse
Affiliation(s)
| | - S Samida
- Royal Perth Hospital , Perth, Australia
| | | | - P Miller
- Royal Perth Hospital , Perth, Australia
| | - S Burrows
- University of Western Australia School of Medicine, , Perth, Australia
- Royal Perth Hospital Research Foundation , Perth, Australia
| |
Collapse
|
11
|
Bennett V, Gill C, Miller P, Lewis P, Ypag N, Hamilton-Giachritsis C, Lavi I. Developing a novel co-produced methodology to understand 'real-world' help-seeking in online peer-peer communities by young people experiencing emotional abuse and neglect. Health Expect 2022; 25:3124-3142. [PMID: 36210766 DOI: 10.1111/hex.13621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2022] [Revised: 09/20/2022] [Accepted: 09/21/2022] [Indexed: 11/28/2022] Open
Abstract
BACKGROUND Recent systematic reviews suggest mediating factors (barriers and facilitators) of help-seeking for children and young people (CYP) with a range of mental health problems but highlight the need for a more robust methodology underpinned by theoretical frameworks. Emotional abuse and neglect is the most prevalent and pervasive form of abuse, with many CYP remaining unknown to professional services. These CYP are underrepresented in help-seeking research yet seek help from their peers via anonymous online publicly available message communities. OBJECTIVES To sensitively co-develop qualitative methodology to explore 'real-world' data to inform our understanding of help-seeking for these CYP, and define potential mediators (barriers and facilitators) and mechanisms of change associated with online peer support. METHODS Co-production with 10 young co-researchers (YCoR; aged 14-18 years) from the NeurOX Young People's Advisory Group (YPAG) included co-development and triangulation to apply different research methods (i.e., interpretative phenomenological, thematic and conversation analyses) to analyse rich ethnographic material from 20 publicly available online message conversations between help-seekers experiencing or questioning emotional abuse and neglect. A theoretical model of adolescent help-seeking proposed by Rickwood et al. was used as a conceptual framework to guide methodological development. RESULTS The methodological approach facilitated the identification of barriers and facilitators of help-seeking contextualized to the lives of these CYP: understanding and validating of abuse, emotional competence, fears and uncertainties around disclosure, knowledge, motivational factors and connection/trusted relationships. Notably, positive changes in expressed or perceived 'psychological state' and/or intention to seek help were noticed in 9 of 10 message threads that included a 'conversation' (≥3 posts). Themes associated with change related to connection with supportive peers; compassionate responding and the safeness of the online community. The existing adolescent help-seeking model was found to be too simplistic to account for help-seeking associated with emotional abuse and neglect. CONCLUSION The novel methodological approach offers a meaningful way to explore 'real-world' data with YCoR, for a population underrepresented in help-seeking research. Proposed relational mechanisms involve connection, compassion and online communities. Further research coproduced with YCoR with diverse care experiences and characteristics is required to upscale the methodology and further validate and extend the findings. PUBLIC CONTRIBUTION The core study was co-produced with 10 YCoRs from the NeurOX YPAG who have been involved in over 135 h on and offline work. Their roles involved co-deciding the direction of the study, evolving methodology, detailed co-analysis and reflective processes throughout all aspects of the study, interpretation, presentation and discussion of the findings with the NSPCC and Childline, and involvement in all communications. Additional consultation and involvement included further interested members of the NeurOX YPAG for the final online workshop and dissemination outputs.
Collapse
Affiliation(s)
- Vanessa Bennett
- Neuroscience, Ethics and Society Group, Department of Psychiatry, University of Oxford, Oxford, UK
| | - Chloe Gill
- Research and Evidence Team, NSPCC, London, UK
| | | | - Peter Lewis
- Department of Psychiatry, University of Oxford, Oxford, UK
| | - NeurOX Ypag
- Department of Psychiatry, University of Oxford, Oxford, UK
| | | | - Iris Lavi
- Department of Psychiatry, University of Oxford, Oxford, UK
| |
Collapse
|
12
|
Wilson-Robles HM, Bygott T, Kelly TK, Miller TM, Miller P, Matsushita M, Terrell J, Bougoussa M, Butera T. Evaluation of plasma nucleosome concentrations in dogs with a variety of common cancers and in healthy dogs. BMC Vet Res 2022; 18:329. [PMID: 36045415 PMCID: PMC9429572 DOI: 10.1186/s12917-022-03429-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2021] [Accepted: 08/19/2022] [Indexed: 01/02/2023] Open
Abstract
Background Cell free DNA, in the form of nucleosomes, is released into circulation during apoptosis and necrosis in a variety of diseases. They are small fragments of chromosomes that are composed of DNA wrapped around a histone core made of four duplicate histone proteins forming an octamer. The nucleosome compartment is a relatively uninvestigated area of circulating tumor biomarkers in dogs. The objectives of this study were to quantify and better characterize nucleosome concentrations in 528 dogs with various common malignancies and compare them to 134 healthy dogs. Results The sensitivity of increased circulating nucleosome concentrations for the detection of cancer in all dogs was 49.8% with a specificity of 97% with an area under the curve of 68.74%. The top 4 malignancies detected by the test included lymphoma, hemangiosarcoma, histiocytic sarcoma and malignant melanoma. The malignancies least likely to be detected were soft tissue sarcomas, osteosarcoma and mast cell tumors. Conclusions A variety of tumor types may cause increased nucleosome concentrations in dogs. Tumors of hematopoietic origin are most likely to cause elevations and local tumors such as soft tissue sarcomas are least likely to cause elevations in plasma nucleosome concentrations.
Collapse
|
13
|
Miron Y, Miller P, Firth C, Cevikbas F. LB1039 New insights into neuronal itch mechanisms by targeting IL-13Rα1 with eblasakimab. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.1077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
14
|
Babayev M, Capozzi SL, Miller P, McLaughlin KR, Medina SS, Byrne S, Zheng G, Salamova A. PFAS in drinking water and serum of the people of a southeast Alaska community: A pilot study. Environ Pollut 2022; 305:119246. [PMID: 35367506 PMCID: PMC9090981 DOI: 10.1016/j.envpol.2022.119246] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/23/2021] [Revised: 03/22/2022] [Accepted: 03/29/2022] [Indexed: 05/27/2023]
Abstract
Per- and polyfluoroalkyl substances (PFAS) have become a target of rigorous scientific research due to their ubiquitous nature and adverse health effects. However, there are still gaps in knowledge about their environmental fate and health implications. More attention is needed for remote locations with source exposures. This study focuses on assessing PFAS exposure in Gustavus, a small Alaska community, located near a significant PFAS source from airport operations and fire training sites. Residential water (n = 25) and serum (n = 40) samples were collected from Gustavus residents and analyzed for 39 PFAS compounds. In addition, two water samples were collected from the previously identified PFAS source near the community. Fourteen distinct PFAS were detected in Gustavus water samples, including 6 perfluorinated carboxylic acids (PFCAs), 7 perfluorosulfonic acids (PFSAs), and 1 fluorotelomer sulfonate (FTS). ΣPFAS concentrations in residential drinking water ranged from not detected to 120 ng/L. High ΣPFAS levels were detected in two source samples collected from the Gustavus Department of Transportation (14,600 ng/L) and the Gustavus Airport (228 ng/L), confirming these two locations as a nearby major source of PFAS contamination. Seventeen PFAS were detected in serum and ΣPFAS concentrations ranged from 0.0170 to 13.1 ng/mL (median 0.0823 ng/mL). Perfluorooctanesulfonic acid (PFOS) and perfluorohexanesulfonic acid (PFHxS) were the most abundant PFAS in both water and serum samples and comprised up to 70% of ΣPFAS concentrations in these samples. Spearman's correlation analysis revealed PFAS concentrations in water and sera were significantly and positively correlated (r = 0.495; p = 0.0192). Our results confirm a presence of a significant PFAS source near Gustavus, Alaska and suggest that contaminated drinking water from private wells contributes to the overall PFAS body burden in Gustavus residents.
Collapse
Affiliation(s)
- Maksat Babayev
- School of Public Health, Indiana University, Bloomington, IN 47405, United States
| | - Staci L Capozzi
- O'Neill School of Public and Environmental Affairs, Bloomington, Indiana 47405 United States
| | - Pamela Miller
- Alaska Community Action on Toxics, Anchorage, AK 99518, United States
| | | | | | - Samuel Byrne
- Department of Biology, Middlebury College, Middlebury, VT 05753, United States
| | - Guomao Zheng
- School of Environmental Science and Engineering, Southern University of Science and Technology, Shenzhen 518055, China
| | - Amina Salamova
- Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, United States.
| |
Collapse
|
15
|
Jordan-Ward R, von Hippel FA, Zheng G, Salamova A, Dillon D, Gologergen J, Immingan T, Dominguez E, Miller P, Carpenter D, Postlethwait JH, Byrne S, Buck CL. Elevated mercury and PCB concentrations in Dolly Varden (Salvelinus malma) collected near a formerly used defense site on Sivuqaq, Alaska. Sci Total Environ 2022; 826:154067. [PMID: 35217049 PMCID: PMC9078153 DOI: 10.1016/j.scitotenv.2022.154067] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/29/2021] [Revised: 02/11/2022] [Accepted: 02/17/2022] [Indexed: 04/13/2023]
Abstract
Environmental pollution causes adverse health effects in many organisms and contributes to health disparities for Arctic communities that depend on subsistence foods, including the Yupik residents of Sivuqaq (St. Lawrence Island), Alaska. Sivuqaq's proximity to Russia made it a strategic location for U.S. military defense sites during the Cold War. Two radar surveillance stations were installed on Sivuqaq, including at the Northeast Cape. High levels of persistent organic pollutants and toxic metals continue to leach from the Northeast Cape formerly used defense (FUD) site despite remediation efforts. We quantified total mercury (Hg) and polychlorinated biphenyl (PCB) concentrations, and carbon and nitrogen stable isotope signatures, in skin and muscle samples from Dolly Varden (Salvelinus malma), an important subsistence species. We found that Hg and PCB concentrations significantly differed across locations, with the highest concentrations found in fish collected near the FUD site. We found that 89% of fish collected from near the FUD site had Hg concentrations that exceeded the U.S. Environmental Protection Agency's (EPA) unlimited Hg-contaminated fish consumption screening level for subsistence fishers (0.049 μg/g). All fish sampled near the FUD site exceeded the EPA's PCB guidelines for cancer risk for unrestricted human consumption (0.0015 μg/g ww). Both Hg and PCB concentrations had a significant negative correlation with δ13C when sites receiving input from the FUD site were included in the analysis, but these relationships were insignificant when input sites were excluded. δ15N had a significant negative correlation with Hg concentration, but not with PCB concentration. These results suggest that the Northeast Cape FUD site remains a point source of Hg and PCB pollution and contributes to higher concentrations in resident fish, including subsistence species. Moreover, elevated Hg and PCB levels in fish near the FUD site may pose a health risk for Sivuqaq residents.
Collapse
Affiliation(s)
- Renee Jordan-Ward
- Department of Biological Sciences, Northern Arizona University, 617 S. Beaver St., Flagstaff, AZ 86011, USA
| | - Frank A von Hippel
- Department of Community, Environment and Policy, Mel & Enid Zuckerman College of Public Health, University of Arizona, 1295 N. Martin Ave., P.O. Box 245210, Tucson, AZ 85724, USA.
| | - Guomao Zheng
- School of Environmental Science and Engineering, Southern University of Science and Technology, Shenzhen 518055, China
| | - Amina Salamova
- Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
| | - Danielle Dillon
- Department of Biological Sciences, Northern Arizona University, 617 S. Beaver St., Flagstaff, AZ 86011, USA
| | - Jesse Gologergen
- Alaska Community Action on Toxics, 1225 E. International Airport Road, Suite 220, Anchorage, AK 99518, USA
| | - Tiffany Immingan
- Alaska Community Action on Toxics, 1225 E. International Airport Road, Suite 220, Anchorage, AK 99518, USA
| | - Elliott Dominguez
- Department of Biological Sciences, Northern Arizona University, 617 S. Beaver St., Flagstaff, AZ 86011, USA
| | - Pamela Miller
- Alaska Community Action on Toxics, 1225 E. International Airport Road, Suite 220, Anchorage, AK 99518, USA
| | - David Carpenter
- Institute for Health and the Environment, University at Albany, 5 University Place, Rensselaer, NY 12144, USA
| | - John H Postlethwait
- Institute of Neuroscience, University of Oregon, 1254 University of Oregon, Eugene, OR 97403, USA
| | - Samuel Byrne
- Middlebury College, Department of Biology and Global Health Program, 14 Old Chapel Rd, Middlebury, VT 05753, USA
| | - C Loren Buck
- Department of Biological Sciences, Northern Arizona University, 617 S. Beaver St., Flagstaff, AZ 86011, USA
| |
Collapse
|
16
|
Smith S, Godley S, Miller P, Anderson A, Heap S. Expanding physiotherapy placement capacity: Clinical educators’ experiences of implementing a coaching approach to supervision. Physiotherapy 2022. [DOI: 10.1016/j.physio.2021.12.321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
17
|
Murphy B, Miller P, Molley A, O'Toole G, Curtin P, Flavin R, O'Shea K, Cassar-Gheiti A, Hurson C. COVID-19, "Lockdown" and Achilles Tendon Ruptures. Ir Med J 2021; 114:437. [PMID: 38224027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Subscribe] [Scholar Register] [Indexed: 01/16/2024]
|
18
|
Hussaini N, Coughlan L, Flynn D, Miller P, Daly TK, Crowley B, Hussaini A. The Impact of Climate Change on Healthcare. Ir Med J 2021; 114:422. [PMID: 35476382] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Affiliation(s)
- N Hussaini
- School of Medicine, Trinity College Dublin, Dublin, Ireland
- Association of Medical Students, Ireland
| | - L Coughlan
- School of Medicine, Trinity College Dublin, Dublin, Ireland
- Association of Medical Students, Ireland
| | - D Flynn
- School of Medicine, National University of Ireland, Galway, Galway, Ireland
- Association of Medical Students, Ireland
| | - P Miller
- School of Medicine, National University of Ireland, Galway, Galway, Ireland
- Association of Medical Students, Ireland
| | - T K Daly
- School of Medicine, University College Cork, Cork, Ireland
- Association of Medical Students, Ireland
| | - B Crowley
- School of Medicine, University College Cork, Cork, Ireland
- Association of Medical Students, Ireland
| | - A Hussaini
- Lifeline Cardiology Clinic, Limerick, Ireland
- Mater Private Hospital, Cork, Ireland
| |
Collapse
|
19
|
Miller P, Adachi J, Albergaria BH, Cheung AM, Chines A, Gielen E, Langdahl B, Miyauchi A, Oates M, Reid I, Ruiz Santiago N, Vanderkelen M, Yang W, Yu Z. OP0297 EFFICACY AND SAFETY OF ROMOSOZUMAB AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND MILD-TO-MODERATE CHRONIC KIDNEY DISEASE. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.4539] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Osteoporosis and renal insufficiency are coexisting disease states in a substantial proportion of postmenopausal women. Since bisphosphonates are generally contraindicated in patients with estimated glomerular filtration rate (eGFR) <35 mL/min, it is important to evaluate other osteoporosis treatments in this setting.Objectives:To determine if baseline renal function affects the efficacy and safety of romosozumab.Methods:We performed post hoc analyses of two clinical trials of romosozumab in postmenopausal women with osteoporosis. In ARCH (NCT01631214), 4,093 patients were randomised 1:1 to romosozumab 210 mg monthly or alendronate 70 mg weekly for 12 months (mean age: 74.3 years; 96.1% with prevalent vertebral fractures [VFx]). In FRAME (NCT01575834), 7,180 patients were randomised 1:1 to romosozumab 210 mg or placebo monthly for 12 months (mean age: 70.9 years; 18.3% with prevalent VFx). For these analyses, patients were categorised by baseline eGFR (mL/min/1.73m2): normal renal function (eGFR ≥90), mild renal insufficiency (eGFR 60–89), or moderate renal insufficiency (eGFR 30–59). Least squares mean (LSM) percent change from baseline in bone mineral density (BMD) at the lumbar spine, total hip, and femoral neck; incidence of new VFx and adverse events (AEs); and changes in renal function were assessed for each eGFR category at Month 12 of the double-blind treatment period.Results:At baseline, most patients had mild/moderate renal insufficiency: 84% in ARCH, 88% in FRAME. In both studies, change from baseline in BMD was significantly higher in the romosozumab group across baseline eGFR categories (Figure). There was an interaction between BMD increase and renal function, and although BMD increase was not as large in women with impaired renal function, differences between romosozumab and control groups remained significant (Figure). In ARCH, among patients with eGFR ≥90, 60–89, and 30–59, the incidence of new VFx (romosozumab vs alendronate) at Month 12 was 3.3% vs 7.3%, 3.2% vs 3.9%, and 3.4% vs 6.2% in ARCH. In FRAME, the incidence of new VFx (romosozumab vs placebo) at Month 12 was 0.5% vs 3.0%, 0.4% vs 1.5%, and 0.6% vs 2.1%.In both studies, the incidences of AEs and serious AEs were similar in both treatment groups within and across eGFR categories. AEs of mild-to-moderate hypocalcaemia (investigator reported) occurred in two patients in ARCH (one romosozumab [eGFR 60–89] and one alendronate [eGFR ≥90]), and one patient in FRAME (romosozumab [eGFR 60–89]). Five patients in ARCH (all in the alendronate group) and 19 patients in FRAME (14 romosozumab, 5 placebo) had decreases in serum Ca levels (albumin adjusted); in the romosozumab group all were mild (<LLN–8.0 mg/dL) or moderate (<8.0–7.0 mg/dL). A similar percentage of patients in each group had changes in renal function over 12 months of treatment.Conclusion:The efficacy and safety of romosozumab vs alendronate or placebo was similar among postmenopausal women with osteoporosis and different levels of renal function.Acknowledgments:This study was funded by Amgen, Astellas and UCB Pharma. Editorial services were provided by Costello Medical.Disclosure of Interests:Paul Miller Grant/research support from: Amgen, Radius Health, Ultragenyx, Consultant of: Amgen, Radius Health, Jonathan Adachi Consultant of: Amgen, Speakers bureau: Amgen, Ben-Hur Albergaria Consultant of: Amgen Inc., Eli Lilly, Speakers bureau: Amgen Inc., Eli Lilly, Angela M Cheung Consultant of: Amgen, Eli Lilly, Arkadi Chines Shareholder of: Amgen Inc., Employee of: Amgen Inc., Evelien Gielen Consultant of: Amgen Inc., Takeda, Sandoz and UCB Pharma, Speakers bureau: Amgen Inc., Takeda, Sandoz and UCB Pharma, Bente Langdahl Grant/research support from: Amgen, NovoNordisk, Consultant of: Amgen Inc., Eli Lilly, UCB Pharma, Akimitsu Miyauchi Consultant of: Amgen Inc., Astellas BioPharma K.K., Teijin Pharma, Mary Oates Shareholder of: Amgen Inc., Employee of: Amgen Inc., Ian Reid Consultant of: Amgen Inc., Eli Lilly, Speakers bureau: Amgen Inc., Eli Lilly, Norma Ruiz Santiago Shareholder of: Amgen Inc., Employee of: Amgen Inc., Mark Vanderkelen Employee of: UCB Pharma, Wenjing Yang Shareholder of: Amgen Inc., Employee of: Amgen Inc., Zhigang Yu Shareholder of: Amgen Inc., Employee of: Amgen Inc.
Collapse
|
20
|
Zheng G, Miller P, von Hippel FA, Buck CL, Carpenter DO, Salamova A. Legacy and emerging semi-volatile organic compounds in sentinel fish from an arctic formerly used defense site in Alaska. Environ Pollut 2020; 259:113872. [PMID: 32069693 PMCID: PMC7082201 DOI: 10.1016/j.envpol.2019.113872] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/14/2019] [Revised: 12/09/2019] [Accepted: 12/21/2019] [Indexed: 05/20/2023]
Abstract
The Arctic is subject to long-range atmospheric deposition of globally-distilled semi-volatile organic compounds (SVOCs) that bioaccumulate and biomagnify in lipid-rich food webs. In addition, locally contaminated sites may also contribute SVOCs to the arctic environment. Specifically, Alaska has hundreds of formerly used defense (FUD) sites, many of which are co-located with Alaska Native villages in remote parts of the state. The purpose of this study was to investigate the extent of SVOC contamination on Alaska's St. Lawrence Island through the analysis of sentinel fish, the ninespine stickleback (Pungitius pungitius), collected from Troutman Lake located within the watershed of an FUD site and adjacent to the Yupik community of Gambell. We measured the concentrations of legacy and emerging SVOCs in 303 fish samples (81 composites), including polychlorinated biphenyls (PCBs), polybrominated diphenyl ethers (PBDEs), organophosphate esters (OPEs) and their diester metabolites, and per- and poly-fluoroalkyl substances (PFAS). PBDEs and PCBs were the most abundant SVOC groups found in stickleback with ΣPBDE and ΣPCB median concentrations of 25.8 and 10.9 ng/g ww, respectively, followed by PFAS (median ΣPFAS 7.22 ng/g ww). ΣOPE and ΣOPE metabolite concentrations were lower with median concentrations of 4.97 and 1.18 ng/g ww, respectively. Chemical patterns and distributions based on correlations and comparison with SVOC concentrations in stickleback from other parts of the island suggest strong local sources of PCBs, PBDEs, and PFAS on St. Lawrence Island.
Collapse
Affiliation(s)
- Guomao Zheng
- O'Neill School of Public and Environmental Affairs, Indiana University, Bloomington, IN, 47405, USA
| | - Pamela Miller
- Alaska Community Action on Toxics, Anchorage, AK, 99518, USA
| | - Frank A von Hippel
- Department of Biological Sciences, Northern Arizona University, Flagstaff, AZ 86011, USA
| | - C Loren Buck
- Department of Biological Sciences, Northern Arizona University, Flagstaff, AZ 86011, USA
| | - David O Carpenter
- University at Albany, State University of New York, Albany, NY, 12222, USA
| | - Amina Salamova
- O'Neill School of Public and Environmental Affairs, Indiana University, Bloomington, IN, 47405, USA.
| |
Collapse
|
21
|
Tomihama R, Boggs H, Miller P, Dudley K, Rickards E, Abou-zamzam A, Kiang S. 3:45 PM Abstract No. 161 Pediatric renal artery stenosis: a 19-year experience in management and outcomes at a tertiary pediatric hospital. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
22
|
Suratwala T, Steele R, Destino J, Wong L, Norton M, Laurence T, Aracne-Ruddle C, Miller P, Shen N, Feit M, Ray N, Carr W, Rivers C, Peters V, Jeppson S, Malone D, Greene W. Sapphire advanced mitigation process: wet etch to expose sub-surface damage and increase laser damage resistance and mechanical strength. Appl Opt 2020; 59:1602-1610. [PMID: 32225658 DOI: 10.1364/ao.381739] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/08/2019] [Accepted: 12/19/2019] [Indexed: 06/10/2023]
Abstract
A novel, to the best of our knowledge, method of wet chemical etching of sapphire workpieces (such as optics, wafers, windows, and cones), called the sapphire advanced mitigation process (or sapphire AMP), has been developed that exposes sub-surface mechanical damage created during the optical fabrication process and significantly enhances the surface laser damage resistance ($ \gt {2{\times}}$>2×) and mechanical strength (up to $\sim{2.6{\times}}$∼2.6×). Sapphire AMP involves first treating the workpiece with a mixture of sulfuric and phosphoric acid $([{\rm H_{2}{\rm SO_{4}}}]:[{\rm H_{3}{\rm PO_{4}}}]=1:3)$([H2SO4]:[H3PO4]=1:3) at 220°C, followed with phosphoric acid at 160°C, then with sodium hydroxide base (NaOH) and surfactant at 40°C, and finally with a high-pressure deionized water spray rinse. Sapphire AMP has been demonstrated on both A- and C-plane sapphire workpieces. The mechanism of this etch process involves the reaction of the sapphire $({\rm Al_{2}}{\rm O_{3}})$(Al2O3) surface with sulfuric acid $({\rm H_{2}}{\rm SO_{4}})$(H2SO4) forming aluminum sulfate $[{{\rm Al}_2}{({{\rm SO}_4})_3}]$[Al2(SO4)3], which has low solubility. The high phosphoric acid content in the first and second steps of sapphire AMP results in the efficient conversion of ${{\rm Al}_2}{({{\rm SO}_4})_3}$Al2(SO4)3 to aluminum phosphate $({\rm AlPO_{4}})$(AlPO4), which is very soluble, greatly reducing reaction product redeposition on the workpiece surface. Sapphire AMP is shown to expose sub-surface mechanical damage on the sapphire surface created during the grinding and polishing processes, whose etched morphology has either isotropic or anisotropic evolution depending on the nature of the initial surface damage. Sapphire AMP was also designed to remove the key known surface, laser absorbing precursors (namely, foreign chemical impurities, the fracture surface layer of preexisting sub-surface damage, and reaction product or foreign species redeposition or precipitation). Static and sliding indention induced surface microfractures on sapphire are shown after sapphire AMP to have a significant decrease in the fast photoluminescence intensity (a known metric for measuring the degree of laser damaging absorbing precursors). In addition, the onset of laser damage (at 351 nm 3 ns) on sapphire AMP treated workpieces was shown to increase in fluence from $\sim{4}$∼4 to $ \gt {9}.{5}\;{{\rm J/cm}^2}$>9.5J/cm2. Finally, biaxial ball-on-ring mechanical tests on sapphire disks showed an increase in the failure stress from 340 MPa (with pre-existing 28 µm flaws) to $\sim{900}\;{\rm MPa}$∼900MPa after sapphire AMP, which is attributed to the blunting of the surface microfractures.
Collapse
|
23
|
Ayers S, Bond R, Webb R, Miller P, Bateson K. Perinatal mental health and risk of child maltreatment: A systematic review and meta-analysis. Child Abuse Negl 2019; 98:104172. [PMID: 31698284 DOI: 10.1016/j.chiabu.2019.104172] [Citation(s) in RCA: 33] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/15/2019] [Revised: 08/27/2019] [Accepted: 08/31/2019] [Indexed: 05/26/2023]
Abstract
BACKGROUND Mental health problems in parents have been identified as a risk factor for child maltreatment. The perinatal period (from conception to 1 year) is a critical period but it is unclear whether perinatal mental health problems are also associated with increased risk. OBJECTIVE To review evidence on perinatal mental health and risk of child maltreatment. METHODS Searches were conducted on six databases and 24 studies reported in 30 papers identified. Studies were conducted in seven countries, mainly the USA (n = 14). Sample sizes ranged from 48-14,893 and most examined mothers (n = 17). Studies were conducted in community (n = 17) or high-risk (n = 7) samples. RESULTS The majority of studies found a relationship between parental perinatal mental health problems and risk of child maltreatment, but inconsistent findings were observed between and within studies. The few studies that examined fathers (n = 6) all found a relationship between fathers' mental health and risk of child maltreatment. Meta-analysis of 17 studies (n = 22,042) showed perinatal mental health problems increased risk of child maltreatment by OR 3.04 (95% CI 2.29-4.03). This relationship was moderated by type of sample, with larger effects for risk of child maltreatment in high-risk samples. The relationship was not moderated by type of mental illness, child maltreatment; methodological or measurement factors. CONCLUSION The association between perinatal mental health and risk of child maltreatment is similar to that observed at other times during childhood. Methodological heterogeneity and inconsistent findings mean conclusions are tentative and need to be considered alongside other individual, family and social/cultural risk factors.
Collapse
Affiliation(s)
- Susan Ayers
- Centre for Maternal and Child Health Research, School of Health Sciences, City, University of London, Northampton Square, London, EC1V 0HB, United Kingdom.
| | - Rod Bond
- School of Psychology, University of Sussex, Falmer, East Sussex, BN1 9RH, United Kingdom
| | - Rebecca Webb
- Centre for Maternal and Child Health Research, School of Health Sciences, City, University of London, Northampton Square, London, EC1V 0HB, United Kingdom
| | - Pamela Miller
- National Society for the Prevention of Cruelty to Children (NSPCC), Weston House, 42 Curtain Road, London, EC2A 3NH, United Kingdom
| | - Karen Bateson
- National Society for the Prevention of Cruelty to Children (NSPCC), Weston House, 42 Curtain Road, London, EC2A 3NH, United Kingdom
| |
Collapse
|
24
|
Miller P, Brook L, Stomski NJ, Ditchburn G, Morrison P. Suicide risk and social support in Australian resource sector employees: A cross-sectional study. J Community Psychol 2019; 47:652-662. [PMID: 30499596 DOI: 10.1002/jcop.22145] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/30/2018] [Revised: 11/08/2018] [Accepted: 11/09/2018] [Indexed: 06/09/2023]
Abstract
This study examines the association between suicide risk and social support in Australian resource sector employees. We included 150 participants, who completed the Beck Hopelessness Scale and MOS-Social Support Survey. Data were analyzed using smallest space analysis and multidimensional scalogram analysis. The analysis identified four distinct regions, which were conceptualized as "confiding," "affection," "companionship," and "practical help." All of these components of social support were associated with hopelessness, which has important clinical implications as hopelessness is related to suicide risk. The results of this study also demonstrated that lower levels of social support, and greater sense of perceived hopelessness tended to lead to Australian resource workers seeking assistance from mental health professionals in the previous year. Attention should turn towards providing interventions that promote social support for employees in Australian resource industry.
Collapse
|
25
|
Sandoval Leon AC, Medina Saenz K, Miller P, Benson A, Calfa C, Mahtani R, Slingerland J, Perez A, Vogel C, Valdes-Albini F, El-Ashry D, Lippman M. Abstract P4-01-07: A comprehensive liquid biopsy in patients undergoing neoadjuvant therapy. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p4-01-07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Precision medicine is revolutionizing breast cancer (BC) care. Comprehensive liquid biopsies are a tool for personalized care in patients with locally advanced breast cancer (LABC). Identifying robust biomarkers as part of a comprehensive liquid biopsy to predict response to treatment is of immense clinical interest.
Methods: After obtaining IRB approval, serial blood samples were collected from patients with LABC undergoing neoadjuvant therapy. Paired biopsies were collected prior to treatment and were sent to Foundation Medicine for next-generation sequencing (NGS). We used a sized-base microfilter technology to capture circulating tumor cells (CTCs) and circulating cancer associated fibroblasts (cCAFs). Patients with one or more CTCs or cCAFs were deemed positive for these tests. Additionally, in collaboration with Foundation Medicine, we extracted circulating tumor DNA (ctDNA) and we analyzed it using the FoundationACT platform. Patients with a detectable genomic alteration in their plasma were considered as having a positive ctDNA test. Our primary objective is to determine if a comprehensive liquid biopsy can serve as a prognostic marker of pathologic complete response (pCR).
Results: For this analysis we describe our findings in the initial blood draw of the first 18 patients enrolled. The mean age is 54 years (38-70). All patients who had their tumors sequenced had a detectable mutation. Consistent with the findings of others, we found TP53 mutations to be the most prevalent at 83.3%. We found that 44% of patients had ctDNA, 68.4% had cCAFs and 78.9% had CTCs. Many patients also had clusters of cells, consisting of one cell type, or co-clusters, consisting of both. 38.9% had CTC clusters, 16.7% had cCAF clusters and 16.7% had co-clusters (CTCs and cCAFs together). Some patients with CTCs did not have cCAFs and vice versa. The number of CTCs and cCAFS did not correlate with stage of disease or receptor status.
Conclusions: We describe a comprehensive liquid biopsy combining a sized-based microfilter technology for CTC and cCAFs identification and the FoundationACT platform for ctDNA analysis is feasible and these biomarkers can be detected in patients with LABC prior to the initiation of neoadjuvant therapy. Our study is accruing rapidly, and we will update our results with the longitudinal collection and the prognostic value of a comprehensive liquid biopsy at the time of the meeting.
Citation Format: Sandoval Leon AC, Medina Saenz K, Miller P, Benson A, Calfa C, Mahtani R, Slingerland J, Perez A, Vogel C, Valdes-Albini F, El-Ashry D, Lippman M. A comprehensive liquid biopsy in patients undergoing neoadjuvant therapy [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P4-01-07.
Collapse
Affiliation(s)
- AC Sandoval Leon
- University of Miami, Miami, Fl; Foundation Medicine, Inc, Cambridge, MA; University of Minnesota, Minneapolis, MN
| | - K Medina Saenz
- University of Miami, Miami, Fl; Foundation Medicine, Inc, Cambridge, MA; University of Minnesota, Minneapolis, MN
| | - P Miller
- University of Miami, Miami, Fl; Foundation Medicine, Inc, Cambridge, MA; University of Minnesota, Minneapolis, MN
| | - A Benson
- University of Miami, Miami, Fl; Foundation Medicine, Inc, Cambridge, MA; University of Minnesota, Minneapolis, MN
| | - C Calfa
- University of Miami, Miami, Fl; Foundation Medicine, Inc, Cambridge, MA; University of Minnesota, Minneapolis, MN
| | - R Mahtani
- University of Miami, Miami, Fl; Foundation Medicine, Inc, Cambridge, MA; University of Minnesota, Minneapolis, MN
| | - J Slingerland
- University of Miami, Miami, Fl; Foundation Medicine, Inc, Cambridge, MA; University of Minnesota, Minneapolis, MN
| | - A Perez
- University of Miami, Miami, Fl; Foundation Medicine, Inc, Cambridge, MA; University of Minnesota, Minneapolis, MN
| | - C Vogel
- University of Miami, Miami, Fl; Foundation Medicine, Inc, Cambridge, MA; University of Minnesota, Minneapolis, MN
| | - F Valdes-Albini
- University of Miami, Miami, Fl; Foundation Medicine, Inc, Cambridge, MA; University of Minnesota, Minneapolis, MN
| | - D El-Ashry
- University of Miami, Miami, Fl; Foundation Medicine, Inc, Cambridge, MA; University of Minnesota, Minneapolis, MN
| | - M Lippman
- University of Miami, Miami, Fl; Foundation Medicine, Inc, Cambridge, MA; University of Minnesota, Minneapolis, MN
| |
Collapse
|
26
|
Sharma U, Miller P, Medina Saenz K, Picon-Ruiz M, Morata-Tarifa C, Spartz A, Troness B, Park DN, Seagroves TN, Slingerland JM, Lippman ME, El-Ashry D. Abstract PD9-10: Circulating CAF/cancer stem cell co-clusters bolster breast cancer metastasis. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-pd9-10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Metastatic disease is the primary cause of breast cancer (BC) mortality. Cancer associated fibroblasts (CAFs) are the majority of stroma in BC and critical players in BC malignancy. For example, CAFs are the main source of SDF-1, a prominent chemokine in the tumor microenvironment (TME) that also imparts stem cell-like characteristics to BC cells. Metastasis occurs due to the transport of circulating tumor cells (CTC) and clusters of CTCs through the vasculature. Stem-like CTCs and clusters have a greater propensity to establish metastasis. We recently identified circulating CAFs (cCAFs) in blood from patients with BC and in spontaneous, syngeneic, and xenograft mouse models of BC. cCAFs not only circulate individually, but are also found in clusters with CTCs. In this study, we examine the role of CAFs in promoting egress of stem-like CTCs (cCSCs), determine the capacity of stem-like CTCs to cluster with CAFs, and evaluate the involvement of CTC/cCAF clustering in augmenting BC metastasis.
Methods: Our model employs NSG mice with orthotopic xenograft implantation of BC cells, primary CAF cell lines, or co-implantation of BC and CAF cell lines. We used two different BC cell lines: the non-metastatic BC cell line, MCF-7, and the highly metastatic primary BC cell line, DT28. We also employed the MMTV-PyMT spontaneous model of BC metastasis, and we used BALB/c mice injected with syngeneic 4T1 or 67nR cells to evaluate cCAFs, CTCs, and cluster egress in preclinical models. Mice were sacrificed at specific time points, and cardiac blood was collected. Blood was filtered using the faCTChecker microfluidic filtration instrument (Circulogix). Filters were stained for IF and cCAFs, CTCs, cCSCs, and clusters were enumerated. Tumors from CAF co-injected mice were evaluated for their stem cell-like phenotype and re-implanted in mice to evaluate tumorigenicity and metastasis.
Results: In spontaneous, syngeneic, and orthotopic xenograft models of BC, cCAFs, CTCs, and cCAF/CTCs co-clusters appear early in tumor development. cCAF/CTC clusters increase in correlation with tumor burden and metastasis. Co-inoculation of CAFs with BC cells resulted in a significant increase in tumor progression, metastasis, and in a substantially higher number of both individual cells and clusters in circulation. Dissociated tumor cells from CAF co-injected tumors had a higher proportion of CD44+stem cell-like cells (CSCs), enhanced ALDH-1 expression, and enhanced mammosphere formation. CD44+ CSCs, individually and in clusters, are found early on in the circulation of mice injected with dissociated tumor cells from CAF co-injected tumors. Upon re-implantation of CAF co-injected dissociated tumor cells without CAFs, dissociated tumor cells showed enhanced tumorigenicity and malignancy.
Conclusion: CAFs are highly motile and cCAFs precede CTCs into circulation and can do so independently of tumor cells. CAFs sustain egress of tumor cells by augmenting malignancy and stemness of BC cells. cCAF clusters with the highly metastatic stem cell-like subset of CTCs bolster metastatic colonization. Targeting primary CAF function and/or cCAF/cCSC co-clusters may provide novel avenues to abrogate BC metastasis.
Citation Format: Sharma U, Miller P, Medina Saenz K, Picon-Ruiz M, Morata-Tarifa C, Spartz A, Troness B, Park DN, Seagroves TN, Slingerland JM, Lippman ME, El-Ashry D. Circulating CAF/cancer stem cell co-clusters bolster breast cancer metastasis [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr PD9-10.
Collapse
Affiliation(s)
- U Sharma
- University of Miami, Miller School of Medicine, Miami, FL; University of Minnesota, Minneapolis, MN; The University of Tennessee Health Science Center, Memphis, TN
| | - P Miller
- University of Miami, Miller School of Medicine, Miami, FL; University of Minnesota, Minneapolis, MN; The University of Tennessee Health Science Center, Memphis, TN
| | - K Medina Saenz
- University of Miami, Miller School of Medicine, Miami, FL; University of Minnesota, Minneapolis, MN; The University of Tennessee Health Science Center, Memphis, TN
| | - M Picon-Ruiz
- University of Miami, Miller School of Medicine, Miami, FL; University of Minnesota, Minneapolis, MN; The University of Tennessee Health Science Center, Memphis, TN
| | - C Morata-Tarifa
- University of Miami, Miller School of Medicine, Miami, FL; University of Minnesota, Minneapolis, MN; The University of Tennessee Health Science Center, Memphis, TN
| | - A Spartz
- University of Miami, Miller School of Medicine, Miami, FL; University of Minnesota, Minneapolis, MN; The University of Tennessee Health Science Center, Memphis, TN
| | - B Troness
- University of Miami, Miller School of Medicine, Miami, FL; University of Minnesota, Minneapolis, MN; The University of Tennessee Health Science Center, Memphis, TN
| | - DN Park
- University of Miami, Miller School of Medicine, Miami, FL; University of Minnesota, Minneapolis, MN; The University of Tennessee Health Science Center, Memphis, TN
| | - TN Seagroves
- University of Miami, Miller School of Medicine, Miami, FL; University of Minnesota, Minneapolis, MN; The University of Tennessee Health Science Center, Memphis, TN
| | - JM Slingerland
- University of Miami, Miller School of Medicine, Miami, FL; University of Minnesota, Minneapolis, MN; The University of Tennessee Health Science Center, Memphis, TN
| | - ME Lippman
- University of Miami, Miller School of Medicine, Miami, FL; University of Minnesota, Minneapolis, MN; The University of Tennessee Health Science Center, Memphis, TN
| | - D El-Ashry
- University of Miami, Miller School of Medicine, Miami, FL; University of Minnesota, Minneapolis, MN; The University of Tennessee Health Science Center, Memphis, TN
| |
Collapse
|
27
|
Martindale A, Trenhaile-Grannemann M, Barnett S, Miller P, Burkey T. 171 Growth performance of weaned pigs fed a high-protein corn co-product. J Anim Sci 2018. [DOI: 10.1093/jas/sky404.649] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- A Martindale
- University of Nebraska,Lincoln, NE, United States
| | | | - S Barnett
- University of Nebraska,Lincoln, NE, United States
| | - P Miller
- University of Nebraska,Lincoln, NE, United States
| | - T Burkey
- University of Nebraska,Lincoln, NE, United States
| |
Collapse
|
28
|
Troy M, Shore B, Miller P, Mahan S, Hedequist D, Heyworth B, Kasser J, Spencer S, Glotzbecker M. A comparison of screw versus drill and curettage epiphysiodesis to correct leg-length discrepancy. J Child Orthop 2018; 12:509-514. [PMID: 30294377 PMCID: PMC6169556 DOI: 10.1302/1863-2548.12.180030] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
PURPOSE To compare two common surgical techniques of epiphysiodesis: drill/curettage epiphysiodesis (PDED) versus cross screw epiphysiodesis (PETS). The hypothesis is that the two techniques have similar efficacy but demonstrate differences in length of hospital stay (LOS), time to return to activity and complication rates. METHODS A retrospective review of growing children and adolescents less than 18 years old who required an epiphysiodesis with leg-length discrepancy (LLD) of 2 cm to 6 cm with minimum two years of follow-up was conducted. Characteristics including age at surgery, gender, epiphysiodesis location, side, operative time, LOS and hardware removal were compared across treatment groups. LLD, expected growth remaining (EGR) and bone age were determined preoperatively and at most-recent visit. The correction ratio (change in EGR) was calculated along with a 95% confidence interval (CI) to assess if correction in leg length was achieved. RESULTS A total of 115 patients underwent epiphysiodesis in the femur (53%), tibia (24%) or a combination (24%). The cohort was 47% male, with a mean age of 12.6 years (7.7 to 17.7) at surgery. Median follow-up was 3.7 years (2.0 to 12.7). In all, 23 patients underwent PETS and 92 patients had PDED. Both treatment groups achieved expected LLD correction. There was no significant difference in median operative time, complication rates or LOS. PETS patients returned to activity at a mean 1.4 months (interquartile range (IQR) 0.7 to 2.1) while PDED patients returned at a mean 2.4 months (IQR 1.7 to 3) (p < 0.001). CONCLUSION Effectiveness in achieving expected correction, LOS and operative time are similar between screw and drill/curettage epiphysiodesis. Patients undergoing PETS demonstrated a faster return to baseline activity than patients with PDED. LEVEL OF EVIDENCE III.
Collapse
Affiliation(s)
- M. Troy
- Department of Orthopaedic Surgery, Boston Children’s Hospital, Boston, Massachusetts, USA
| | - B. Shore
- Department of Orthopaedic Surgery, Boston Children’s Hospital, Boston, Massachusetts, USA
| | - P. Miller
- Department of Orthopaedic Surgery, Boston Children’s Hospital, Boston, Massachusetts, USA
| | - S. Mahan
- Department of Orthopaedic Surgery, Boston Children’s Hospital, Boston, Massachusetts, USA
| | - D. Hedequist
- Department of Orthopaedic Surgery, Boston Children’s Hospital, Boston, Massachusetts, USA
| | - B. Heyworth
- Department of Orthopaedic Surgery, Boston Children’s Hospital, Boston, Massachusetts, USA
| | - J. Kasser
- Department of Orthopaedic Surgery, Boston Children’s Hospital, Boston, Massachusetts, USA
| | - S. Spencer
- Department of Orthopaedic Surgery, Boston Children’s Hospital, Boston, Massachusetts, USA
| | - M. Glotzbecker
- Department of Orthopaedic Surgery, Boston Children’s Hospital, Boston, Massachusetts, USA,Correspondence should be sent to M. Glotzbecker, 300 Longwood Ave, Hunnewell 2, Boston, Massachusetts 02115, USA. E-mail:
| |
Collapse
|
29
|
Byrne SC, Miller P, Seguinot-Medina S, Waghiyi V, Buck CL, von Hippel FA, Carpenter DO. Exposure to perfluoroalkyl substances and associations with serum thyroid hormones in a remote population of Alaska Natives. Environ Res 2018; 166:537-543. [PMID: 29958161 PMCID: PMC6932630 DOI: 10.1016/j.envres.2018.06.014] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/28/2018] [Revised: 05/11/2018] [Accepted: 06/09/2018] [Indexed: 05/17/2023]
Abstract
Perfluoroalkyl substances (PFASs) are known to accumulate in traditional food animals of the Arctic, and arctic indigenous peoples may be exposed via consumption of subsistence-harvested animals. PFASs are suspected of disrupting thyroid hormone homeostasis in humans. The aim of this study is to assess the relationship between serum PFASs and thyroid function in a remote population of Alaska Natives. Serum samples were collected from 85 individuals from St. Lawrence Island, Alaska. The concentrations of 13 PFASs, as well as free and total thyroxine (T4), free and total triiodothyronine (T3), and thyrotropin (TSH) were quantified in serum samples. The relationships between circulating concentrations of PFASs and thyroid hormones were assessed using multiple linear regression fit with generalized estimating equations. Several PFASs, including perfluorooctanoic acid (PFOA) and perfluorononanoic acid (PFNA), were positively associated with TSH concentrations when modeled individually. PFOS and PFNA were significantly associated with free T3 and PFNA was significantly associated with total T3 in models with PFAS*sex interactive terms; these associations suggested negative associations in men and positive associations in women. PFASs were not significantly associated with concentrations of free or total T4. Serum PFASs are associated with circulating thyroid hormone concentrations in a remote population of Alaska Natives. The effects of PFAS exposure on thyroid hormone homeostasis may differ between sexes.
Collapse
Affiliation(s)
- Samuel C Byrne
- Environmental Studies, St. Lawrence University, 23 Romoda Drive, Canton, NY, USA.
| | - Pamela Miller
- Alaska Community Action on Toxics, Anchorage, AK, USA
| | | | - Vi Waghiyi
- Alaska Community Action on Toxics, Anchorage, AK, USA
| | - C Loren Buck
- Department of Biological Sciences & Center for Bioengineering Innovation, Northern Arizona University, Flagstaff, AZ, USA
| | - Frank A von Hippel
- Department of Biological Sciences & Center for Bioengineering Innovation, Northern Arizona University, Flagstaff, AZ, USA
| | - David O Carpenter
- Institute for Health and the Environment, University at Albany, Rensselaer, NY, USA
| |
Collapse
|
30
|
Jumani RS, Bessoff K, Love MS, Miller P, Stebbins EE, Teixeira JE, Campbell MA, Meyers MJ, Zambriski JA, Nunez V, Woods AK, McNamara CW, Huston CD. A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box. Antimicrob Agents Chemother 2018; 62:e01505-17. [PMID: 29339392 PMCID: PMC5913971 DOI: 10.1128/aac.01505-17] [Citation(s) in RCA: 38] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2017] [Accepted: 01/05/2018] [Indexed: 12/21/2022] Open
Abstract
Cryptosporidiosis causes life-threatening diarrhea in children under the age of 5 years and prolonged diarrhea in immunodeficient people, especially AIDS patients. The standard of care, nitazoxanide, is modestly effective in children and ineffective in immunocompromised individuals. In addition to the need for new drugs, better knowledge of drug properties that drive in vivo efficacy is needed to facilitate drug development. We report the identification of a piperazine-based lead compound for Cryptosporidium drug development, MMV665917, and a new pharmacodynamic method used for its characterization. The identification of MMV665917 from the Medicines for Malaria Venture Malaria Box was followed by dose-response studies, in vitro toxicity studies, and structure-activity relationship studies using commercial analogues. The potency of this compound against Cryptosporidium parvum Iowa and field isolates was comparable to that against Cryptosporidium hominis Furthermore, unlike nitazoxanide, clofazimine, and paromomycin, MMV665917 appeared to be curative in a NOD SCID gamma mouse model of chronic cryptosporidiosis. MMV665917 was also efficacious in a gamma interferon knockout mouse model of acute cryptosporidiosis. To determine if efficacy in this mouse model of chronic infection might relate to whether compounds are parasiticidal or parasitistatic for C. parvum, we developed a novel in vitro parasite persistence assay. This assay suggested that MMV665917 was parasiticidal, unlike nitazoxanide, clofazimine, and paromomycin. The assay also enabled determination of the concentration of the compound required to maximize the rate of parasite elimination. This time-kill assay can be used to prioritize early-stage Cryptosporidium drug leads and may aid in planning in vivo efficacy experiments. Collectively, these results identify MMV665917 as a promising lead and establish a new method for characterizing potential anticryptosporidial agents.
Collapse
Affiliation(s)
- R S Jumani
- Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, USA
- Cellular, Molecular and Biomedical Sciences Graduate Program, University of Vermont, Burlington, Vermont, USA
| | - K Bessoff
- Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, USA
| | - M S Love
- California Institute for Biomedical Research, La Jolla, California, USA
| | - P Miller
- Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, USA
| | - E E Stebbins
- Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, USA
| | - J E Teixeira
- Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, USA
| | - M A Campbell
- Saint Louis University School of Medicine, St. Louis, Missouri, USA
| | - M J Meyers
- Saint Louis University School of Medicine, St. Louis, Missouri, USA
| | - J A Zambriski
- Paul G. Allen School for Global Animal Health, College of Veterinary Medicine, Washington State University, Pullman, Washington, USA
| | - V Nunez
- California Institute for Biomedical Research, La Jolla, California, USA
| | - A K Woods
- California Institute for Biomedical Research, La Jolla, California, USA
| | - C W McNamara
- California Institute for Biomedical Research, La Jolla, California, USA
| | - C D Huston
- Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, USA
- Cellular, Molecular and Biomedical Sciences Graduate Program, University of Vermont, Burlington, Vermont, USA
| |
Collapse
|
31
|
Bones B, Burner S, White E, Smith D, Hoth J, Miller P, Dickey K. 3:09 PM Abstract No. 14 When does an osseous pelvic injury require embolization? An exploratory analysis to identify predicting factors for embolization compare those managed with diagnostic angiography only. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
32
|
Miller P, Sharma U, Medina-Saenz K, Yeasky T, Picon-Ruiz M, Morata-Tarifa C, Seagroves T, Slingerland J, Lippman M, El-Ashry D. Abstract P2-01-10: Circulating CAF/CTC complexes and breast cancer metastasis. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p2-01-10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Metastatic disease in breast cancer (BC) is the leading cause of cancer-related mortality among women worldwide. Synergy between cancer cells and non-cancer cells of the tumor microenvironment (TME) are vital for disease progression. Cancer associated fibroblasts (CAFs) are the major cell type in the stroma of BC and are critical mediators of tumor progression and metastasis. Transport of circulating tumor cells (CTCs) and CTC clusters through the vasculature seeds metastasis and clinical and preclinical studies demonstrate that CTC clusters have a higher metastatic potential than individual CTCs. More recently, circulating cancer stem cells (cCSCs) have been implicated as more metastatic than non-CSC CTCs. In our lab, we have demonstrated that CAFs also circulate (cCAFs). We have observed cCAFs in peripheral blood from breast cancer patients and in murine models of breast cancer. Furthermore, we have observed that cCAFs are present in circulation as both individual cells and as well as in complexes with CTCs. Given the integral role of CAFs in BC metastasis, we hypothesize that cCAFs complex with CTCs/cCSCs to bolster BC metastasis.
Methods: cCAF/CTC clusters were identified and enumerated from peripheral blood of patients with BC, and associations with clinical features and disease outcomes were evaluated. Blood was collected by cardiac puncture from PyMT mice from 4 weeks through to the presence of metastases (10 weeks) and cCAF/CTC clusters enumerated. We co-injected CAFs with MCF-7 cellsl into NSG mice, blood collected by cardiac puncture, and cCAF/CTC clusters were enumerated. At time of final sacrifice, tumors were removed and assessed for presence of CSCs. Using our established model of cCAF/CTC clustering in vitro we interrogated cCAF/CTC complexing with both metastatic and poorly metastatic BC cells.
Results: Circulating cCAFs/CTCs clusters are significantly increased in the blood of patients with advanced stage BC and associate not only with severity of disease but also with poorer clinical outcomes. In the spontaneous PyMT mouse model, the appearance of circulating cCAF/CTC clusters increased significantly as tumors grew but prior to metastasis. We demonstrate that metastatic BC cells form clusters with CAFs in vitro while non-metastatic BC cells do not form complexes with CAFs in vitro. Enriching for stem cells from MCF7 mammospheres, resulted in CAF/CSC clusters in vitro. In mice that were co-injected with non-metastatic MCF7 cells and CAFs from a TNBC/Basal-like BC (CAF23) we observed disease metastasis, an enrichment for cancer stem cell (CSC)-like CTCs, and the presence of circulating cCAF/MCF7-CSC clusters.
Conclusions: Circulating clusters of CTCs and cCAFs are characteristic, and potentially causative, of BC metastasis. Observations of cCAF/CTC clusters from preclinical and clinical samples are corroborated by our determination that the ability of BC cells to form complexes with CAFs in vitro is related to the intrinsic metastatic ability of the breast cancer cells. Both in vitro and in circulation, the BC cells in cCAF/cBC clusters are CSCs, so cCAF/cCSC clusters. Disrupting the formation of cCAF/CTC complexes may be a potential strategy to reduce treat or prevent breast cancer metastasis.
Citation Format: Miller P, Sharma U, Medina-Saenz K, Yeasky T, Picon-Ruiz M, Morata-Tarifa C, Seagroves T, Slingerland J, Lippman M, El-Ashry D. Circulating CAF/CTC complexes and breast cancer metastasis [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P2-01-10.
Collapse
Affiliation(s)
- P Miller
- Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; Masonic Cancer Center, University of Minnesota, Minneapolis, MN; University of Tennessee Health Science Center, Memphis, TN
| | - U Sharma
- Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; Masonic Cancer Center, University of Minnesota, Minneapolis, MN; University of Tennessee Health Science Center, Memphis, TN
| | - K Medina-Saenz
- Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; Masonic Cancer Center, University of Minnesota, Minneapolis, MN; University of Tennessee Health Science Center, Memphis, TN
| | - T Yeasky
- Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; Masonic Cancer Center, University of Minnesota, Minneapolis, MN; University of Tennessee Health Science Center, Memphis, TN
| | - M Picon-Ruiz
- Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; Masonic Cancer Center, University of Minnesota, Minneapolis, MN; University of Tennessee Health Science Center, Memphis, TN
| | - C Morata-Tarifa
- Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; Masonic Cancer Center, University of Minnesota, Minneapolis, MN; University of Tennessee Health Science Center, Memphis, TN
| | - T Seagroves
- Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; Masonic Cancer Center, University of Minnesota, Minneapolis, MN; University of Tennessee Health Science Center, Memphis, TN
| | - J Slingerland
- Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; Masonic Cancer Center, University of Minnesota, Minneapolis, MN; University of Tennessee Health Science Center, Memphis, TN
| | - M Lippman
- Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; Masonic Cancer Center, University of Minnesota, Minneapolis, MN; University of Tennessee Health Science Center, Memphis, TN
| | - D El-Ashry
- Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; Masonic Cancer Center, University of Minnesota, Minneapolis, MN; University of Tennessee Health Science Center, Memphis, TN
| |
Collapse
|
33
|
Byrne SC, Miller P, Seguinot-Medina S, Waghiyi V, Buck CL, von Hippel FA, Carpenter DO. Associations between serum polybrominated diphenyl ethers and thyroid hormones in a cross sectional study of a remote Alaska Native population. Sci Rep 2018; 8:2198. [PMID: 29396447 PMCID: PMC5797183 DOI: 10.1038/s41598-018-20443-9] [Citation(s) in RCA: 32] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2017] [Accepted: 01/08/2018] [Indexed: 12/26/2022] Open
Abstract
Polybrominated diphenyl ethers (PBDEs) are ubiquitous environmental pollutants. Arctic indigenous peoples are exposed to PBDEs through a traditional diet high in marine mammals. PBDEs disrupt thyroid homeostasis. The aim of this study was to assess the relationship between serum PBDEs and thyroid function in a remote population of St. Lawrence Island Yupik. Serum samples were collected from 85 individuals from St. Lawrence Island, Alaska and measured for concentrations of PBDEs, free and total thyroxine (T4), free and total triiodothyronine (T3), and thyroid stimulating hormone (TSH). The relationships between PBDEs and thyroid hormones were assessed using multiple linear regression fit with generalized estimating equations. Serum concentrations of several Penta-BDE congeners (BDE-28/33, 47, and 100) were positively associated with concentrations of TSH and free T3, while serum concentration of BDE-153 was negatively associated with total T3 concentrations. Both BDE-47 and 153 remained significantly associated with thyroid hormones when BDE-47, BDE-153, and BDE-209 were covariates in the same model. There were no significant relationships between serum concentrations of PBDEs and either free or total T4. Individual PBDEs are associated with thyroid hormones in serum from a remote population of Alaska Natives, and directions of effect differ by congener.
Collapse
Affiliation(s)
- Samuel C Byrne
- Environmental Studies, St. Lawrence University, Canton, NY, USA.
| | - Pamela Miller
- Alaska Community Action on Toxics, Anchorage, AK, USA
| | | | - Vi Waghiyi
- Alaska Community Action on Toxics, Anchorage, AK, USA
| | - C Loren Buck
- Department of Biological Sciences and Center for Bioengineering Innovation, Northern Arizona University, Flagstaff, AZ, USA
| | - Frank A von Hippel
- Department of Biological Sciences and Center for Bioengineering Innovation, Northern Arizona University, Flagstaff, AZ, USA
| | - David O Carpenter
- Institute for Health and the Environment, University at Albany, Rensselaer, NY, USA
| |
Collapse
|
34
|
Byrne S, Seguinot-Medina S, Miller P, Waghiyi V, von Hippel FA, Buck CL, Carpenter DO. Exposure to polybrominated diphenyl ethers and perfluoroalkyl substances in a remote population of Alaska Natives. Environ Pollut 2017; 231:387-395. [PMID: 28818814 PMCID: PMC6945979 DOI: 10.1016/j.envpol.2017.08.020] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/31/2016] [Revised: 02/04/2017] [Accepted: 08/05/2017] [Indexed: 05/03/2023]
Abstract
BACKGROUND Many Alaska Native communities rely on a traditional marine diet that contains persistent organic pollutants (POPs). The indoor environment is also a source of POPs. Polybrominated diphenyl ethers (PBDEs) and perfluoroalkyl substances (PFASs) are present both in the traditional diet and the home indoor environment. OBJECTIVES We assessed exposure to PBDEs and PFASs among residents of two remote Alaska Native villages on St. Lawrence Island. Ninespine stickleback (Pungitious pungitious) and Alaska blackfish (Dallia pectoralis) were used to detect accumulation of these compounds in the local environment. METHODS Concentrations of PBDEs and PFASs were measured in dust collected from 49 households on St. Lawrence Island, as well as in blood serum from 85 island residents. Resident ninespine stickleback and Alaska blackfish were used as sentinels to detect accumulation of PBDEs and PFASs in the food web. RESULTS Serum concentrations of perfluorononanoic acid (PFNA) and perfluoroundecanoic acid (PFUnDA) were elevated, despite low concentrations of PFASs in dust samples. Concentrations of PBDEs in dust and serum were similar to those from the contiguous United States. Statistical associations between dust and serum concentrations are apparent for a small number of PBDEs, suggesting a possible route of exposure. Predominant compounds were similar between human sera and stickleback; however, blackfish accumulated PFASs not found in either stickleback or human sera. CONCLUSION Household dust contributes to PBDE exposure, but not PFAS exposure. Elevated concentrations of long chain PFASs in serum are likely due to exposure from traditional foods. The presence of both PFASs and PBDEs in sentinel fish species suggests atmospheric deposition and bioaccumulation, as well as local environmental contamination.
Collapse
Affiliation(s)
- Samuel Byrne
- Department of Environmental Studies, 104 Memorial Hall, St. Lawrence University, Canton, NY 13617, USA.
| | | | - Pamela Miller
- Alaska Community Action on Toxics, Anchorage, AK 99503, USA
| | - Vi Waghiyi
- Alaska Community Action on Toxics, Anchorage, AK 99503, USA
| | - Frank A von Hippel
- Department of Biological Sciences and Center for Bioengineering Innovation, Northern Arizona University, Flagstaff, AZ 86011, USA
| | - C Loren Buck
- Department of Biological Sciences and Center for Bioengineering Innovation, Northern Arizona University, Flagstaff, AZ 86011, USA
| | - David O Carpenter
- Institute for Health and the Environment, University at Albany, Albany, NY 12144, USA
| |
Collapse
|
35
|
Lefebvre RA, Miller P, Scaglione JM, Banerjee K, Peterson JL, Radulescu G, Robb KR, Thompson AB, Liljenfeldt H, Lefebvre JP. Development of Streamlined Nuclear Safety Analysis Tool for Spent Nuclear Fuel Applications. NUCL TECHNOL 2017. [DOI: 10.1080/00295450.2017.1314747] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- R. A. Lefebvre
- Oak Ridge National Laboratory, Reactor and Nuclear Systems Division, P.O. Box 2008, Bldg. 5700, Oak Ridge, Tennessee 37831-6170
| | - P. Miller
- Oak Ridge National Laboratory, Reactor and Nuclear Systems Division, P.O. Box 2008, Bldg. 5700, Oak Ridge, Tennessee 37831-6170
| | - J. M. Scaglione
- Oak Ridge National Laboratory, Reactor and Nuclear Systems Division, P.O. Box 2008, Bldg. 5700, Oak Ridge, Tennessee 37831-6170
| | - K. Banerjee
- Oak Ridge National Laboratory, Reactor and Nuclear Systems Division, P.O. Box 2008, Bldg. 5700, Oak Ridge, Tennessee 37831-6170
| | - J. L. Peterson
- Oak Ridge National Laboratory, Reactor and Nuclear Systems Division, P.O. Box 2008, Bldg. 5700, Oak Ridge, Tennessee 37831-6170
| | - G. Radulescu
- Oak Ridge National Laboratory, Reactor and Nuclear Systems Division, P.O. Box 2008, Bldg. 5700, Oak Ridge, Tennessee 37831-6170
| | - K. R. Robb
- Oak Ridge National Laboratory, Reactor and Nuclear Systems Division, P.O. Box 2008, Bldg. 5700, Oak Ridge, Tennessee 37831-6170
| | - A. B. Thompson
- Oak Ridge National Laboratory, Reactor and Nuclear Systems Division, P.O. Box 2008, Bldg. 5700, Oak Ridge, Tennessee 37831-6170
| | - H. Liljenfeldt
- Oak Ridge National Laboratory, Reactor and Nuclear Systems Division, P.O. Box 2008, Bldg. 5700, Oak Ridge, Tennessee 37831-6170
| | - J. P. Lefebvre
- Oak Ridge National Laboratory, Reactor and Nuclear Systems Division, P.O. Box 2008, Bldg. 5700, Oak Ridge, Tennessee 37831-6170
| |
Collapse
|
36
|
Miller P, Kidwell KM, Thomas D, Sabel M, Rae JM, Hayes DF, Hudson BI, El-Ashry D, Lippman ME. Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome. Breast Cancer Res Treat 2017; 166:85-94. [PMID: 28717852 DOI: 10.1007/s10549-017-4366-6] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2017] [Accepted: 06/27/2017] [Indexed: 10/19/2022]
Abstract
PURPOSE Elevated S100A8 expression has been observed in cancers of the bladder, esophagus, colon, ovary, and breast. S100A8 is expressed by breast cancer cells as well as by infiltrating immune and myeloid cells. Here we investigate the association of elevated S100A8 protein expression in breast cancer cells and in breast tumor stroma with survival outcomes in a cohort of breast cancer patients. PATIENTS AND METHODS Tissue microarrays (TMA) were constructed from breast cancer specimens from 417 patients with stage I-III breast cancer treated at the University of Michigan Comprehensive Cancer Center between 2004 and 2006. Representative regions of non-necrotic tumor and distant normal tissue from each patient were used to construct the TMA. Automated quantitative immunofluorescence (AQUA) was used to measure S100A8 protein expression, and samples were scored for breast cancer cell and stromal S100A8 expression. S100A8 staining intensity was assessed as a continuous value and by exploratory dichotomous cutoffs. Associations between breast cancer cell and stromal S100A8 expression with disease-free survival and overall survival were determined using the Kaplan-Meier method and Cox proportional hazard models. RESULTS High breast cancer cell S100A8 protein expression (as indicated by AQUA scores), as a continuous measure, was a significant prognostic factor for OS [univariable hazard ratio (HR) 1.24, 95% confidence interval (CI) 1.00-1.55, p = 0.05] in this patient cohort. Exploratory analyses identified optimal S100A8 AQUA score cutoffs within the breast cancer cell and stromal compartments that significantly separated survival curves for the complete cohort. Elevated breast cancer cell and stromal S100A8 expression, indicated by higher S100A8 AQUA scores, significantly associates with poorer breast cancer outcomes, regardless of estrogen receptor status. CONCLUSIONS Elevated breast cancer cell and stromal S1008 protein expression are significant indicators of poorer outcomes in early stage breast cancer patients. Evaluation of S100A8 protein expression may provide additional prognostic information beyond traditional breast cancer prognostic biomarkers.
Collapse
Affiliation(s)
- P Miller
- University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA.
| | - K M Kidwell
- University of Michigan School of Public Health, Department of Biostatistics, Ann Arbor, MI, USA
| | - D Thomas
- University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
| | - M Sabel
- University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
| | - J M Rae
- University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
| | - D F Hayes
- University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
| | - B I Hudson
- University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA
| | - D El-Ashry
- University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA
| | - M E Lippman
- University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA
| |
Collapse
|
37
|
Hamblin A, Greenfield DM, Gilleece M, Salooja N, Kenyon M, Morris E, Glover N, Miller P, Braund H, Peniket A, Shaw BE, Snowden JA. Provision of long-term monitoring and late effects services following adult allogeneic haematopoietic stem cell transplant: a survey of UK NHS-based programmes. Bone Marrow Transplant 2017; 52:889-894. [DOI: 10.1038/bmt.2017.67] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2016] [Revised: 01/15/2017] [Accepted: 01/23/2017] [Indexed: 12/28/2022]
|
38
|
Hamza AV, Nikroo A, Alger E, Antipa N, Atherton LJ, Barker D, Baxamusa S, Bhandarkar S, Biesiada T, Buice E, Carr E, Castro C, Choate C, Conder A, Crippen J, Dylla-Spears R, Dzenitis E, Eddinger S, Emerich M, Fair J, Farrell M, Felker S, Florio J, Forsman A, Giraldez E, Hein N, Hoover D, Horner J, Huang H, Kozioziemski B, Kroll J, Lawson B, Letts SA, Lord D, Mapoles E, Mauldin M, Miller P, Montesanti R, Moreno K, Parham T, Nathan B, Reynolds J, Sater J, Segraves K, Seugling R, Stadermann M, Strauser R, Stephens R, Suratwala TI, Swisher M, Taylor JS, Wallace R, Wegner P, Wilkens H, Yoxalla B. Target Development for the National Ignition Campaign. Fusion Science and Technology 2017. [DOI: 10.13182/fst15-163] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- A. V. Hamza
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - A. Nikroo
- General Atomics, La Jolla, California 92121
| | - E. Alger
- General Atomics, La Jolla, California 92121
| | - N. Antipa
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - L. J. Atherton
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - D. Barker
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - S. Baxamusa
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - S. Bhandarkar
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - T. Biesiada
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - E. Buice
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - E. Carr
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - C. Castro
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - C. Choate
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - A. Conder
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - J. Crippen
- General Atomics, La Jolla, California 92121
| | - R. Dylla-Spears
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - E. Dzenitis
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | | | - M. Emerich
- General Atomics, La Jolla, California 92121
| | - J. Fair
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - M. Farrell
- General Atomics, La Jolla, California 92121
| | - S. Felker
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - J. Florio
- General Atomics, La Jolla, California 92121
| | - A. Forsman
- General Atomics, La Jolla, California 92121
| | | | - N. Hein
- General Atomics, La Jolla, California 92121
| | - D. Hoover
- General Atomics, La Jolla, California 92121
| | - J. Horner
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - H. Huang
- General Atomics, La Jolla, California 92121
| | - B. Kozioziemski
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - J. Kroll
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - B. Lawson
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - S. A. Letts
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - D. Lord
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - E. Mapoles
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - M. Mauldin
- General Atomics, La Jolla, California 92121
| | - P. Miller
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - R. Montesanti
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - K. Moreno
- General Atomics, La Jolla, California 92121
| | - T. Parham
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - B. Nathan
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - J. Reynolds
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - J. Sater
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - K. Segraves
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - R. Seugling
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - M. Stadermann
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | | | | | - T. I. Suratwala
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - M. Swisher
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - J. S. Taylor
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - R. Wallace
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - P. Wegner
- Lawrence Livermore National Laboratory, Livermore, California 94550
| | - H. Wilkens
- General Atomics, La Jolla, California 92121
| | - B. Yoxalla
- Lawrence Livermore National Laboratory, Livermore, California 94550
| |
Collapse
|
39
|
Miller P, Kidwell K, Thomas D, Sabel M, Rae J, Hayes DF, Lippman ME, El-Ashry D. Abstract P4-12-13: High intratumoral and stromal S100A8 expression is prognostic of poor outcome in breast cancer. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p4-12-13] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: S100A8 and S100A9 are members of a family of calcium binding proteins that regulate inflammatory response, and are biomarkers of inflammatory diseases, S100A8/A9 preferentially form heterodimers that interact with their receptor, RAGE, to activate signaling pathways (ERK1/2 MAPK, JNK, and NF-κB) and stimulate tumor cells. Elevated expression of S100A8/A9 has been observed in cancers of the bladder, esophagus, colon, ovary, and breast. S100A8/A9 are expressed intratumorally by cancer cells and in the stroma by infiltrating immune and myeloid cells as well. We investigated the associations of elevated expression of intratumoral and stromal S100A8 with survival outcomes in breast cancer.
Methods: Tissue microarrays (TMA) were constructed from breast cancer specimens from patients with stage I-III breast cancer treated at the University of Michigan Comprehensive Cancer Center between 2004-2006, ensuring a minimum of 10-year follow-up. Each patient was represented on the TMA by representative regions of non-necrotic tumor and distant normal tissue. Automative Quantitative Immunofluorescence (AQUA) was performed for S100A8 protein, and samples were scored for intratumoral and stromal S100A8 expression. S100A8 staining was assessed as a continuous value and by exploratory dichotomous cutoffs. Associations with disease-free survival (DFS) or overall survival (OS) and S100A8 expression, either as continuous value or based on the exploratory cutoffs, were determined using the Kaplan-Meier method and Cox proportional hazards models.
Results: In the entire patient cohort, high intratumoral S100A8 expression, as a continuous measure, was a significant prognostic factor for OS (univariable hazard ratio [HR] 1.26, 95% confidence interval [CI] 1.02-1.56, p=0.036), and for DFS (multivariable HR [95%CI] = 1.24 [1.01-1.53], p = 0.043). Exploratory analyses demonstrated optimal cutoffs of intratumoral and intrastromal staining that greatly separated survival curves. We evaluated whether the prognostic significance of S100A8 expression is different in breast cancer patients based on hormone receptor status and determined that neither intratumoral nor stromal S100A8 expression were significantly associated with outcomes.
Conclusions: Elevated intratumoral and stromal expression of S100A8 are significant indicators of poor outcome in breast cancer patients. These data further support a biological role for S100A8 signaling in mammary carcinogenesis and aggressive tumor behavior. Evaluation of S100A8 protein expression might provide additional prognostic information beyond traditional breast cancer prognostic biomarkers. Further validation is necessary to investigate these findings.
Citation Format: Miller P, Kidwell K, Thomas D, Sabel M, Rae J, Hayes DF, Lippman ME, El-Ashry D. High intratumoral and stromal S100A8 expression is prognostic of poor outcome in breast cancer [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P4-12-13.
Collapse
Affiliation(s)
- P Miller
- University of Miami Sylvester Comprehensive Cancer Center, Miami, FL; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
| | - K Kidwell
- University of Miami Sylvester Comprehensive Cancer Center, Miami, FL; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
| | - D Thomas
- University of Miami Sylvester Comprehensive Cancer Center, Miami, FL; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
| | - M Sabel
- University of Miami Sylvester Comprehensive Cancer Center, Miami, FL; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
| | - J Rae
- University of Miami Sylvester Comprehensive Cancer Center, Miami, FL; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
| | - DF Hayes
- University of Miami Sylvester Comprehensive Cancer Center, Miami, FL; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
| | - ME Lippman
- University of Miami Sylvester Comprehensive Cancer Center, Miami, FL; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
| | - D El-Ashry
- University of Miami Sylvester Comprehensive Cancer Center, Miami, FL; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
| |
Collapse
|
40
|
Sharma U, Miller P, Speransky S, Medina-Saenz K, Ferrer P, Lippman M, El-Ashry D. Abstract P4-03-18: A hierarchy of cancer associated fibroblasts in situ and in circulation promote breast cancer metastasis. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p4-03-18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Metastasis is the primary cause of breast cancer mortality. Interactions between cancer cells and non-cancer cells of the tumor microenvironment (TME) are pivotal in governing tumor initiation, progression and metastasis, and cancer associated fibroblasts (CAFs) are critical orchestrators of these interactions. We recently identified circulating CAFs (cCAFs) as a novel circulating biomarker associated with metastatic breast cancer. We established CAF cell lines from dissociated luminal A, ER- Her-2 amplified, and triple-negative/basal-like (TN) breast tumors. We demonstrated that “aggressive” CAFs differentially secrete miRNAs that contribute to ER-negativity, activated growth factor signaling, and induction of EMT in breast cancers compared to “indolent” CAFs. We hypothesized that a hierarchy exists within CAFs regarding their ability to facilitate tumor progression and metastasis. Here we demonstrate that CAFs derived from aggressive TN breast tumors differ from those derived from more indolent Luminal A breast tumors in secretion of cytokines and chemokines that can confer differential effects on the behavior of breast cancer cells. We also demonstrate that “aggressive” CAFs more potently facilitate tumor progression and metastasis than “indolent” CAFs. We additionally evaluated if “aggressive” and “indolent” CAFs differ in their ability to mobilize CTCs and circulating CAFs into circulation.
Methods: Conditioned media (CM) from “aggressive” and “indolent” CAFs was analyzed for chemokine/cytokine expression. Luminal A breast cancer cells (MCF-7) or primary tumor cells from an aggressive TN tumor (DT28) were injected into the mammary fat pad of 6-8 week old female NSG mice, either alone or in combination with CAF19-I or CAF23-A. Tumor progression was monitored and mice were examined for metastasis at necropsy. Tissues were harvested for histology and blood was collected by cardiac puncture. Plasma was analyzed for cytokine/chemokine expression and blood was processed for enumeration of circulating tumor cells (CTCs) and cCAFs.
Results: “Aggressive” CAF CM had significantly higher levels of a number of factors, including IL-8, SDF-1, and CXCL1, compared to “indolent” CAF CM. MCF-7 cells co-injected with “aggressive” CAFs formed tumors much faster than those co-injected with the “indolent” CAFs or without CAFs. While DT28 cells readily form tumors and metastasize in the NSG model, fewer DT28 cells do not form metastases in the timeframe that this same lower number of DT28 cells co-injected with “aggressive” CAFs demonstrated robust tumor growth and developed metastases in liver and pancreas. DT28 cells co-injected with “indolent” CAFs did not exhibit metastases.
Conclusion: The data presented here further demonstrate that there is a hierarchy within CAFs regarding their ability to facilitate tumor growth and metastasis, and that this may largely be mediated by secreted soluble factors. “Aggressive” CAFs may retain their programmed role in circulation and accelerate metastasis more than “indolent” CAFs. We suggest that targeting CAFs in situ and in circulation and disrupting their interactions with breast cancer cells could provide novel strategies to combat breast cancer and breast cancer metastasis.
Citation Format: Sharma U, Miller P, Speransky S, Medina-Saenz K, Ferrer P, Lippman M, El-Ashry D. A hierarchy of cancer associated fibroblasts in situ and in circulation promote breast cancer metastasis [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P4-03-18.
Collapse
|
41
|
Bones B, Carrier A, Zinsmeister C, Yen L, Requarth J, Miller P. Infectious sequela after splenic injury: angioembolization is associated with higher infection rates. J Vasc Interv Radiol 2017. [DOI: 10.1016/j.jvir.2016.12.753] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
42
|
Jakel P, Kenney J, Ludan N, Miller P, McNair N, Matesic E. Effects of the Use of the Provider Resilience Mobile Application in Reducing Compassion Fatigue in Oncology Nursing. Clin J Oncol Nurs 2016; 20:611-616. [DOI: 10.1188/16.cjon.611-616] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
43
|
Zak J, Vives V, Szumska D, Vernet A, Schneider JE, Miller P, Slee EA, Joss S, Lacassie Y, Chen E, Escobar LF, Tucker M, Aylsworth AS, Dubbs HA, Collins AT, Andrieux J, Dieux-Coeslier A, Haberlandt E, Kotzot D, Scott DA, Parker MJ, Zakaria Z, Choy YS, Wieczorek D, Innes AM, Jun KR, Zinner S, Prin F, Lygate CA, Pretorius P, Rosenfeld JA, Mohun TJ, Lu X. ASPP2 deficiency causes features of 1q41q42 microdeletion syndrome. Cell Death Differ 2016; 23:1973-1984. [PMID: 27447114 PMCID: PMC5136487 DOI: 10.1038/cdd.2016.76] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2016] [Revised: 06/09/2016] [Accepted: 06/13/2016] [Indexed: 11/09/2022] Open
Abstract
Chromosomal abnormalities are implicated in a substantial number of human developmental syndromes, but for many such disorders little is known about the causative genes. The recently described 1q41q42 microdeletion syndrome is characterized by characteristic dysmorphic features, intellectual disability and brain morphological abnormalities, but the precise genetic basis for these abnormalities remains unknown. Here, our detailed analysis of the genetic abnormalities of 1q41q42 microdeletion cases identified TP53BP2, which encodes apoptosis-stimulating protein of p53 2 (ASPP2), as a candidate gene for brain abnormalities. Consistent with this, Trp53bp2-deficient mice show dilation of lateral ventricles resembling the phenotype of 1q41q42 microdeletion patients. Trp53bp2 deficiency causes 100% neonatal lethality in the C57BL/6 background associated with a high incidence of neural tube defects and a range of developmental abnormalities such as congenital heart defects, coloboma, microphthalmia, urogenital and craniofacial abnormalities. Interestingly, abnormalities show a high degree of overlap with 1q41q42 microdeletion-associated abnormalities. These findings identify TP53BP2 as a strong candidate causative gene for central nervous system (CNS) defects in 1q41q42 microdeletion syndrome, and open new avenues for investigation of the mechanisms underlying CNS abnormalities.
Collapse
Affiliation(s)
- J Zak
- Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, UK
| | - V Vives
- Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, UK
| | - D Szumska
- Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 7BN, UK
| | - A Vernet
- Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 7BN, UK
| | - J E Schneider
- Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 7BN, UK
| | - P Miller
- Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, UK
| | - E A Slee
- Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, UK
| | - S Joss
- Queen Elizabeth University Hospital Glasgow, Glasgow G51 4TF, UK
| | - Y Lacassie
- Department of Pediatrics, Louisiana State University, New Orleans, LA 70118, USA
- Genetics Services, Children's Hospital New Orleans, New Orleans, LA 70118, USA
| | - E Chen
- Kaiser Permanente, San Francisco Medical Center, San Francisco, CA 94115, USA
| | - L F Escobar
- St Vincent Children's Hospital, Indianapolis, IN 46260, USA
| | - M Tucker
- St Vincent Children's Hospital, Indianapolis, IN 46260, USA
| | - A S Aylsworth
- Departments of Pediatrics and Genetics, University of North Carolina, Chapel Hill, NC 27599, USA
| | - H A Dubbs
- Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA
| | - A T Collins
- Seattle Children's Hospital, Seattle, WA 98105, USA
| | - J Andrieux
- Institute of Medical Genetics, Jeanne de Flandre Hospital, CHRU de Lille, Lille 59000, France
| | | | - E Haberlandt
- Clinical Department of Pediatrics, Innsbruck Medical University, Innsbruck A-6020, Austria
| | - D Kotzot
- Division of Human Genetics, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck A-6020, Austria
| | - D A Scott
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
| | - M J Parker
- Sheffield Children's Hospital NHS Foundation Trust, Western Bank, Sheffield, S10 2TH, UK
| | - Z Zakaria
- Institute for Medical Research, Kuala Lumpur, Jalan Pahang 50588, Malaysia
| | - Y S Choy
- Prince Court Medical Centre, Kuala Lumpur 50450, Malaysia
| | - D Wieczorek
- Institute of Human Genetics, University Clinic Essen, Duisburg-Essen University, Essen 45122, Germany
- Institute of Human Genetics, University Clinic, Heinrich-Heine University, Düsseldorf 40225, Germany
| | - A M Innes
- Department of Medical Genetics and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada T3B 6A8
| | - K R Jun
- Department of Laboratory Medicine, Haeundae Paik Hospital, Inje University, Haeundae-gu, Busan, Korea
| | - S Zinner
- Seattle Children's Hospital, Seattle, WA 98105, USA
| | - F Prin
- The Francis Crick Institute Mill Hill Laboratory, London NW7 1AA, UK
| | - C A Lygate
- Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 7BN, UK
| | - P Pretorius
- Department of Neuroradiology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford OX3 9DU, UK
| | - J A Rosenfeld
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
| | - T J Mohun
- The Francis Crick Institute Mill Hill Laboratory, London NW7 1AA, UK
| | - X Lu
- Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, UK
| |
Collapse
|
44
|
Saxton DI, Brown P, Seguinot-Medina S, Eckstein L, Carpenter DO, Miller P, Waghiyi V. Erratum to: Environmental health and justice and the right to research: institutional review board denials of community-based chemical biomonitoring of breast milk. Environ Health 2016; 15:82. [PMID: 27473124 PMCID: PMC4967344 DOI: 10.1186/s12940-016-0165-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2016] [Accepted: 07/22/2016] [Indexed: 06/06/2023]
Affiliation(s)
- Dvera I Saxton
- Department of Anthropology, College of Social Sciences, California State University, Fresno, 5242N. Backer Ave. Peters Business Building M/S 20, Fresno, CA, 93740, USA.
| | - Phil Brown
- Social Science Environmental Health Research Institute, Northeastern University, 318 INV, Boston, MA, 02115, USA
| | - Samarys Seguinot-Medina
- Alaska Community Action on Toxics, 505W. Northern Lights; Suite 205, Anchorage, AK, 99503, USA
| | - Lorraine Eckstein
- Alaska Community Action on Toxics, 505W. Northern Lights; Suite 205, Anchorage, AK, 99503, USA
| | - David O Carpenter
- Institute for Health and the Environment, University at Albany, 5 University Pl., Rm. A217, Rensselaer, NY, 12144, USA
| | - Pamela Miller
- Alaska Community Action on Toxics, 505W. Northern Lights; Suite 205, Anchorage, AK, 99503, USA
| | - Vi Waghiyi
- Alaska Community Action on Toxics, 505W. Northern Lights; Suite 205, Anchorage, AK, 99503, USA
- Native Village of Savoonga Tribal Member, St. Lawrence Island, AK, USA
| |
Collapse
|
45
|
Bennett D, Bellinger DC, Birnbaum LS, Bradman A, Chen A, Cory-Slechta DA, Engel SM, Fallin MD, Halladay A, Hauser R, Hertz-Picciotto I, Kwiatkowski CF, Lanphear BP, Marquez E, Marty M, McPartland J, Newschaffer CJ, Payne-Sturges D, Patisaul HB, Perera FP, Ritz B, Sass J, Schantz SL, Webster TF, Whyatt RM, Woodruff TJ, Zoeller RT, Anderko L, Campbell C, Conry JA, DeNicola N, Gould RM, Hirtz D, Huffling K, Landrigan PJ, Lavin A, Miller M, Mitchell MA, Rubin L, Schettler T, Tran HL, Acosta A, Brody C, Miller E, Miller P, Swanson M, Witherspoon NO. Project TENDR: Targeting Environmental Neuro-Developmental Risks The TENDR Consensus Statement. Environ Health Perspect 2016; 124:A118-22. [PMID: 27479987 PMCID: PMC4937840 DOI: 10.1289/ehp358] [Citation(s) in RCA: 97] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/19/2023]
Abstract
Summary: Children in America today are at an unacceptably high risk of developing neurodevelopmental disorders that affect the brain and nervous system including autism, attention deficit hyperactivity disorder, intellectual disabilities, and other learning and behavioral disabilities. These are complex disorders with multiple causes—genetic, social, and environmental. The contribution of toxic chemicals to these disorders can be prevented. Approach: Leading scientific and medical experts, along with children’s health advocates, came together in 2015 under the auspices of Project TENDR: Targeting Environmental Neuro-Developmental Risks to issue a call to action to reduce widespread exposures to chemicals that interfere with fetal and children’s brain development. Based on the available scientific evidence, the TENDR authors have identified prime examples of toxic chemicals and pollutants that increase children’s risks for neurodevelopmental disorders. These include chemicals that are used extensively in consumer products and that have become widespread in the environment. Some are chemicals to which children and pregnant women are regularly exposed, and they are detected in the bodies of virtually all Americans in national surveys conducted by the U.S. Centers for Disease Control and Prevention. The vast majority of chemicals in industrial and consumer products undergo almost no testing for developmental neurotoxicity or other health effects. Conclusion: Based on these findings, we assert that the current system in the United States for evaluating scientific evidence and making health-based decisions about environmental chemicals is fundamentally broken. To help reduce the unacceptably high prevalence of neurodevelopmental disorders in our children, we must eliminate or significantly reduce exposures to chemicals that contribute to these conditions. We must adopt a new framework for assessing chemicals that have the potential to disrupt brain development and prevent the use of those that may pose a risk. This consensus statement lays the foundation for developing recommendations to monitor, assess, and reduce exposures to neurotoxic chemicals. These measures are urgently needed if we are to protect healthy brain development so that current and future generations can reach their fullest potential.
Collapse
|
46
|
Enright HA, Felix SH, Fischer NO, Mukerjee EV, Soscia D, Mcnerney M, Kulp K, Zhang J, Page G, Miller P, Ghetti A, Wheeler EK, Pannu S. Long-term non-invasive interrogation of human dorsal root ganglion neuronal cultures on an integrated microfluidic multielectrode array platform. Analyst 2016; 141:5346-57. [PMID: 27351032 DOI: 10.1039/c5an01728a] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Scientific studies in drug development and toxicology rely heavily on animal models, which often inaccurately predict the true response for human exposure. This may lead to unanticipated adverse effects or misidentified risks that result in, for example, drug candidate elimination. The utilization of human cells and tissues for in vitro physiological platforms has become a growing area of interest to bridge this gap and to more accurately predict human responses to drugs and toxins. The effects of new drugs and toxins on the peripheral nervous system are often investigated with neurons isolated from dorsal root ganglia (DRG), typically with one-time measurement techniques such as patch clamping. Here, we report the use of our multi-electrode array (MEA) platform for long-term noninvasive assessment of human DRG cell health and function. In this study, we acquired simultaneous optical and electrophysiological measurements from primary human DRG neurons upon chemical stimulation repeatedly through day in vitro (DIV) 23. Distinct chemical signatures were noted for the cellular responses evoked by each chemical stimulus. Additionally, the cell viability and function of the human DRG neurons were consistent through DIV 23. To the best of our knowledge, this is the first report on long-term measurements of the cell health and function of human DRG neurons on a MEA platform. Future generations will include higher electrode numbers in customized arrangements as well as integration with different tissue types on a single device. This platform will provide a valuable testing tool for both rodent and human cells, enabling a more comprehensive risk assessment for drug candidates and toxicants.
Collapse
Affiliation(s)
- H A Enright
- Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USA
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Domingo A, Coelho R, Cortes E, Garcia-Cortes B, Mas F, Mejuto J, Miller P, Ramos-Cartelle A, Santos MN, Yokawa K. Is the tiger shark Galeocerdo cuvier a coastal species? Expanding its distribution range in the Atlantic Ocean using at-sea observer data. J Fish Biol 2016; 88:1223-1228. [PMID: 26817438 DOI: 10.1111/jfb.12887] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/20/2015] [Revised: 08/27/2015] [Accepted: 11/21/2015] [Indexed: 06/05/2023]
Abstract
The occurrence of tiger shark Galeocerdo cuvier in the Atlantic Ocean was assessed using at-sea observer data from multiple pelagic longline fisheries. Geographic positions of 2764 G. cuvier recorded between 1992 and 2013 and covering a wide area of the Atlantic Ocean were compared with the currently accepted distribution ranges of the species. Most records fell outside those ranges in both the Southern and Northern Hemispheres, which strongly suggests that the distribution range of G. cuvier in the open ocean is considerably larger than previously described.
Collapse
Affiliation(s)
- A Domingo
- Dirección Nacional de Recursos Acuáticos (DINARA), Laboratorio de Recursos Pelágicos (LaRPe), Constituyente, 1497, Montevideo, Uruguay
| | - R Coelho
- Portuguese Institute for the Ocean and Atmosphere (IPMA, I.P.), Avenida 5 de Outubro s/n, 8700-305, Olhão, Portugal
| | - E Cortes
- National Oceanographic and Atmospheric Administration, National Marine Fisheries Service, Southeast Fisheries Science Center, Panama City Laboratory, Panama City, FL, 32408, U.S.A
| | - B Garcia-Cortes
- Instituto Español de Oceanografía, P. O. Box 130, 15080, A Coruña, España
| | - F Mas
- Dirección Nacional de Recursos Acuáticos (DINARA), Laboratorio de Recursos Pelágicos (LaRPe), Constituyente, 1497, Montevideo, Uruguay
- Centro de Investigación y Conservación Marina (CICMAR), Av. Giannattasio Km. 30, El Pinar, Uruguay
| | - J Mejuto
- Instituto Español de Oceanografía, P. O. Box 130, 15080, A Coruña, España
| | - P Miller
- Dirección Nacional de Recursos Acuáticos (DINARA), Laboratorio de Recursos Pelágicos (LaRPe), Constituyente, 1497, Montevideo, Uruguay
- Centro de Investigación y Conservación Marina (CICMAR), Av. Giannattasio Km. 30, El Pinar, Uruguay
| | - A Ramos-Cartelle
- Instituto Español de Oceanografía, P. O. Box 130, 15080, A Coruña, España
| | - M N Santos
- Portuguese Institute for the Ocean and Atmosphere (IPMA, I.P.), Avenida 5 de Outubro s/n, 8700-305, Olhão, Portugal
| | - K Yokawa
- National Research Institute of Far Seas Fisheries, 5-7-1 Orido, Shimizu-ku, Shizuoka-City, Shizuoka, 424 8633, Japan
| |
Collapse
|
48
|
Dempsey NG, Miller P, Lippman M. Abstract P2-06-03: Leukemia inhibitory factor receptor as a tumor suppressor: A study on migration and invasion of breast cancer cells upon LIFR stimulation. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p2-06-03] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
BACKGROUND: Tumorigenesis is the result of a step-wise process during which a mutation activates an oncogene or inactivates a tumor suppressor gene. Identification of these genes is critical in order to develop effective therapies for breast cancer patients. Our group previously discovered the Leukemia Inhibitory Factor Receptor (LIFR) as a novel tumor suppressor gene via an in vivo RNAi screen in HMLE cells. HMLE is a partially transformed non-tumorigenic cell line; these cells can become tumorigenic with a single mutation, such as the Ras mutation that creates the HMLER line. HMLEs were transduced using an shRNA library targeting the entire human genome, and stably transfected cells were xenografted into NOD/SCID mice. Genomic DNA from resultant primary tumors were analyzed for the shRNA sequences that, when integrated, made HMLEs tumorigenic. LIFR emerged from this screen as a novel candidate tumor suppressor gene in breast cancer. Here we report on the decreased migration and invasion of breast cancer cells activated by LIFR stimulation.
METHODS: HMLER cells were plated at 500,000 cells per well of a six-well plate. Twenty-four hours later, HMLERs were treated with 100, 25, 12.5, 5, 2.5, or 0 ng/ml recombinant hLIF. Protein lysates were analyzed for phospho-STAT3 induction upon LIF stimulation. Based on the results, we selected 25 ng/ml as the appropriate hLIF concentration to maximally stimulate LIFR in the migration assay described here. HMLERs were serum starved for 8 hours. DMEM with 10% fetal bovine serum was added to the bottom of the migration assay plate as a chemoattractant. The cells were suspended in DMEM with 0.1% bovine serum albumin and either treated with 25 ng/ml LIF or no LIF. Thereafter, 25,000 cells were added to either a Corning Biocoat Matrigel Invasion Chamber or a control insert lacking a migration matrix. The migration assay plate was incubated at 37°C and the cells were allowed to migrate for 20 hours. Migrated cells were enumerated under the light microscope and a migration percentage was calculated.
RESULTS: In the first portion of the study, we found that low concentrations of LIF (2.5 ng/ml) resulted in p-STAT3 induction in HMLERs, but that p-STAT3 was maximally induced with 25 ng/ml of LIF. In the invasion and migration assay, HMLER cells that had not been treated with LIF displayed an aggressively invasive and migratory phenotype with 61.1% migration in matrigel compared to control inserts without the migration matrix. When HMLERs were treated with 25 ng/ml LIF, the cells displayed decreased invasion and migration with only 50.0% of cells migrating. Based on these results, LIFR stimulation inhibits the invasion and migration of breast cancer cells.
CONCLUSIONS: As a tumor suppressor gene, LIFR is vital to the normal functioning of a non-cancerous cell, and its loss can produce a tumorigenic and metastatic phenotype. Treatment with LIF converts aggressively metastatic breast cancer cells to a less invasive phenotype. Through a deeper understanding of LIFR's tumor suppressor effects, we can harness the anti-tumorigenic and anti-metastatic properties of LIFR stimulation and develop targeted therapies to prevent growth and metastasis of breast cancer.
Citation Format: Dempsey NG, Miller P, Lippman M. Leukemia inhibitory factor receptor as a tumor suppressor: A study on migration and invasion of breast cancer cells upon LIFR stimulation. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P2-06-03.
Collapse
Affiliation(s)
- NG Dempsey
- University of Miami Miller School of Medicine, Miami, FL
| | - P Miller
- University of Miami Miller School of Medicine, Miami, FL
| | - M Lippman
- University of Miami Miller School of Medicine, Miami, FL
| |
Collapse
|
49
|
O'Connell SE, Jackson BR, Edwardson CL, Yates T, Biddle SJH, Davies MJ, Dunstan D, Esliger D, Gray L, Miller P, Munir F. Providing NHS staff with height-adjustable workstations and behaviour change strategies to reduce workplace sitting time: protocol for the Stand More AT (SMArT) Work cluster randomised controlled trial. BMC Public Health 2015; 15:1219. [PMID: 26646026 PMCID: PMC4673711 DOI: 10.1186/s12889-015-2532-5] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2015] [Accepted: 11/19/2015] [Indexed: 01/03/2023] Open
Abstract
BACKGROUND High levels of sedentary behaviour (i.e., sitting) are a risk factor for poor health. With high levels of sitting widespread in desk-based office workers, office workplaces are an appropriate setting for interventions aimed at reducing sedentary behaviour. This paper describes the development processes and proposed intervention procedures of Stand More AT (SMArT) Work, a multi-component randomised control (RCT) trial which aims to reduce occupational sitting time in desk-based office workers within the National Health Service (NHS). METHODS/DESIGN SMArT Work consists of 2 phases: 1) intervention development: The development of the SMArT Work intervention takes a community-based participatory research approach using the Behaviour Change Wheel. Focus groups will collect detailed information to gain a better understanding of the most appropriate strategies, to sit alongside the provision of height-adjustable workstations, at the environmental, organisational and individual level that support less occupational sitting. 2) intervention delivery and evaluation: The 12 month cluster RCT aims to reduce workplace sitting in the University Hospitals of Leicester NHS Trust. Desk-based office workers (n = 238) will be randomised to control or intervention clusters, with the intervention group receiving height-adjustable workstations and supporting techniques based on the feedback received from the development phase. Data will be collected at four time points; baseline, 3, 6 and 12 months. The primary outcome is a reduction in sitting time, measured by the activPAL(TM) micro at 12 months. Secondary outcomes include objectively measured physical activity and a variety of work-related health and psycho-social measures. A process evaluation will also take place. DISCUSSION This study will be the first long-term, evidence-based, multi-component cluster RCT aimed at reducing occupational sitting within the NHS. This study will help form a better understanding and knowledge base of facilitators and barriers to creating a healthier work environment and contribute to health and wellbeing policy. TRIAL REGISTRATION ISRCTN10967042 . Registered 2 February 2015.
Collapse
Affiliation(s)
- S E O'Connell
- Leicester Diabetes Centre, University Hospitals of Leicester, Leicester, UK.
| | - B R Jackson
- School of Sport, Exercise and Health Sciences, Loughborough University, Leicestershire, UK.
| | - C L Edwardson
- Diabetes Research Centre, University of Leicester, Leicester, UK. .,NIHR Leicester-Loughborough Diet, Lifestyle, and Physical Activity Biomedical Research Unit, Leicester, UK.
| | - T Yates
- Diabetes Research Centre, University of Leicester, Leicester, UK. .,NIHR Leicester-Loughborough Diet, Lifestyle, and Physical Activity Biomedical Research Unit, Leicester, UK.
| | - S J H Biddle
- School of Sport, Exercise and Health Sciences, Loughborough University, Leicestershire, UK. .,NIHR Leicester-Loughborough Diet, Lifestyle, and Physical Activity Biomedical Research Unit, Leicester, UK. .,Institute of Sport, Exercise and Active Living, Victoria University, Melbourne, Australia.
| | - M J Davies
- Leicester Diabetes Centre, University Hospitals of Leicester, Leicester, UK. .,Diabetes Research Centre, University of Leicester, Leicester, UK. .,NIHR Leicester-Loughborough Diet, Lifestyle, and Physical Activity Biomedical Research Unit, Leicester, UK.
| | - D Dunstan
- School of Public Health, The University of Queensland, Brisbane, Queensland, Australia. .,Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. .,Department of Medicine, Monash University, Melbourne, VIC, Australia. .,Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia. .,School of Exercise and Nutrition Sciences, Deakin University, Burwood, VIC, Australia. .,School of Sport Science, Exercise and Health, The University of Western Australia, Perth, WA, Australia. .,Mary MacKillop Institute for Health Research, The Australian Catholic University, Melbourne, VIC, Australia.
| | - D Esliger
- School of Sport, Exercise and Health Sciences, Loughborough University, Leicestershire, UK. .,NIHR Leicester-Loughborough Diet, Lifestyle, and Physical Activity Biomedical Research Unit, Leicester, UK.
| | - L Gray
- Diabetes Research Centre, University of Leicester, Leicester, UK.
| | - P Miller
- School of Sport, Exercise and Health Sciences, Loughborough University, Leicestershire, UK.
| | - F Munir
- School of Sport, Exercise and Health Sciences, Loughborough University, Leicestershire, UK.
| |
Collapse
|
50
|
Saxton DI, Brown P, Seguinot-Medina S, Eckstein L, Carpenter DO, Miller P, Waghiyi V. Environmental health and justice and the right to research: institutional review board denials of community-based chemical biomonitoring of breast milk. Environ Health 2015; 14:90. [PMID: 26606980 PMCID: PMC4659157 DOI: 10.1186/s12940-015-0076-x] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2015] [Accepted: 11/17/2015] [Indexed: 05/04/2023]
Abstract
Recently, conflicts and challenges have emerged regarding environmental justice and research ethics for some indigenous communities. Alaska Community Action on Toxics (ACAT) responded to community requests for breast milk biomonitoring and conceived the Breast Milk Pilot Study (BMPS). Despite having community support and federal and private funding, the BMPS remains incomplete due to repeated disapprovals by the Alaska Area IRB (Institutional Review Board). In this commentary, we explore the consequences of years of IRB denials, in terms of health inequalities, environmental justice, and research ethics. We highlight the greater significance of this story with respect to research in Alaska Native communities, biomonitoring, and global toxics regulation. We offer suggestions to community-based researchers conducting biomonitoring projects on how to engage with IRBs in order to cultivate reflective, context-based research ethics that better consider the needs and concerns of communities.
Collapse
Affiliation(s)
- Dvera I Saxton
- Department of Anthropology, College of Social Sciences, California State University, Fresno, 5242N. Backer Ave. Peters Business Building M/S 20, Fresno, CA, 93740, USA.
| | - Phil Brown
- Northeastern University, Social Science Environmental Health Research Institute, 318 INV, Boston, MA, 02115, USA.
| | - Samarys Seguinot-Medina
- Alaska Community Action on Toxics, 505W. Northern Lights; Suite 205, Anchorage, AK, 99503, USA.
| | - Lorraine Eckstein
- Alaska Community Action on Toxics, 505W. Northern Lights; Suite 205, Anchorage, AK, 99503, USA.
| | - David O Carpenter
- University at Albany, Institute for Health and the Environment, 5 University Pl., Rm. A217, Rensselaer, NY, 12144, USA.
| | - Pamela Miller
- Alaska Community Action on Toxics, 505W. Northern Lights; Suite 205, Anchorage, AK, 99503, USA.
| | - Vi Waghiyi
- Alaska Community Action on Toxics, 505W. Northern Lights; Suite 205, Anchorage, AK, 99503, USA.
- Native Village of Savoonga Tribal Member, St. Lawrence Island, AK, USA.
| |
Collapse
|